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The aim of the present project is to study five Traditional Chinese Medicines (TCNI) 
used traditionally in China for the treatment of cancer. They are Dolichos lablab L., 
Gekko swinhonis Gunther. Illicium verum Hook., f Lonicerajaponica Thunb. and Iris 
tectorum Maxim. 
Solvent extractions of the TCMs were subjected to bioassay-guided fractionation and 
isolation, yielding series of fractions with increasing purity and cytotoxicity. The 
cytotoxicity assay used comprised four human cancer cell lines (COR-L233,02 
MCF-7 and HepG2) and two human normal cell lines (MRC-5 and 16HBE14o-). 
The separation of organic components was carried out mainly by means of TLC, VLC 
and HPLC. Isolation and purification of bioactive compounds from the active extract 
of I. tectorum, the most potent source tested. led to the identification of two known 
flavonoids (tectorigenin and 7-0-methyl-aromadendrin), two known triterpenes 
(isoiridogermanal and iridobelamal A) and two novel triterpenes. The structures of 
the latter were determined by mass spectrometry and infrared and 2D nuclear 
magnetic resonance spectroscopic techniques. 
Induction of apoptosis by the isolated compounds was investigated using flow 
cytometry with quadrant analysis, and confirmed by fluorescence microscopy. 
Furthermore, cell cycle specific cytotoxicity was determined by DNA analysis. The 
selectivity of cytotoxicity activity, modes of action and structure-activity relationships 
of the compounds are discussed. 
Also, a cell culture-based prodrug assay was established for high-throughput 
screening of potential glucosides, which are inactive in vitro but may be metabolized 
to active aglycones in ilvo. 
In summary. the results obtained showed that selection based on ethnophan-nacology. Z-- ý 
together with a robust and reliable method to detect biolo ical activity, can be a useful t-- 9 
approach for exploring traditional medicines for novel cytotoxic substances. 
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16HBE14o- human bronchial epithelial cell line 
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CHAPTERI 
INTRODUCTION 
1.1 Classification of cancer 
Generally, a cell population that evolves to be able to disregard the normal controls of 
proliferation and territory becomes a cancer (Ponder, 2001). Neoplasms are classified 
as being benign or malignant; malignant neoplasms are equivalent to cancer. 
Different cancers are described according to their cell of origin and the tissue in which 
they arise (Roger et al., 2006) (see Table 1-1). 
Epithelium 0 Glandular, e. g., prostate: adenocarcinoma 
(carcinoma) 0 Squamous, e. g., cervix: carcinoma 
0 Smooth muscle: leiomyosarcoma; benign 
hyperproliferation is called a leiomyoma 
Mesenchyma (fibroid) 
(sarcoma) 0 Bone: osteosarcoma 
0 Fat cells: liposarcoma; benign 
hyperproliferation is called a lipoma 
Nervous system 
Eye: retinoblastorna 
0 Astrocytes: astrocytoma 
0 Myeloid cells: myelocytic leukaemia 
White bood cells 0 Lymphocytes: lymphocytic leukaernia 
(leukaemia) 
0 Lymphoma: solid tumour derived from B- or 
T-lymphocytes 
Table 1-1: Terminology of cancer (from Roger et al., 2006) 
Indeed, cancer is many diseases. There are several initiating causes, several cofactors 
and promoters, and several kinds of cellular damage inflicted on the body's own cells. 
Cancer arises from cells in the body that were once normal cells. The factors that 
determine the incidence are largely exogenous. Exogenous causative agents or factors 
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that have been identified in human include: cigarette smoking, occupational and 
environmental chemicals, radiation. dietary factors, lifestyle and socioeconomic 
factors, and specific viruses (Anonymous, 2006). 
1.2 Epidemiology of cancer 
Cancer is a major cause of morbidity in the United Kingdom (Anonymous, 2006a). 
Each year more than a quarter of a million people are newly diagnosed with cancer. 
Overall it is estimated that more than one in three people will develop some form of 
cancer during their lifetime (Anonymous, 2006a). As shown in Figure I-1, there are 
more than 200 different types of cancer, but four of them (breast, lung, large bowel 
[colorectal] and prostate cancer) account for over half of all new cases in 2002. 
Breast cancer is the most common cancer in the UK despite the fact that it is rare in 
men. Prostate cancer has overtaken lung cancer to become the most commonly 
diagnosed cancer in UK males, with more than 3 1,000 cases diagnosed in 2002. Lung 
cancer is the second most common cancer for males, with around 23,000 cases 
annually (Anonymous, 2006a). In 2004,153,397 people died of cancer in the UK, 
deaths from cancers of the lung (22%), bowel (11%), breast (8%) and prostate (6%) 
together account for around 47% of all cancer deaths (Anonymous, 2006b). 
In the United States, cancer is the second most common cause of death, exceeded only 
by heart disease. In the US, cancer accounts for I of every 4 deaths. About 564,380 
Americans are expected to die of cancer in 2006, more than 1,500 people a day 
(Anonymous, 2006). 
The global burden of cancer continues to increase. In the year 2000,5.3 million men 
and 4.7 million women developed a malignant turnour and 6.2 million died of the 
disease. Given the present trends in smoking prevalence and the adoption of 
unhealthy lifestyles, the number of new cases is expected to reach 15 million by 2020. 
Worldwide, 12% of people die of cancer and in industrialized countries more than one 
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1.3 Cell biology 
The eukaryotic cell cycle consists of a series of events that are involved in the garowth. Z-- 
replication, and division of cells (Lodish and Damell, 1995). The cell cycle can be 
subdivided into two major stages, interphase (a phase between mitotic events) and 
mitosis (see Figure 1-2). There are three distinct, successive stages within interphase, 






Figure 1-2: Diagram of Cell cycle phases (from www. bdbiosciences. com) 
During G, (first gap phase), cells "monitor" their environment and upon receipt of 
requisite signals, they grow (synthesize RNA and proteins). The ploidy of a cell in G, 
is 2n. If conditions are right, cells "commit" to DNA synthesis (S phase) and replicate 
their chromosomal DNA. The ploidy of cells during S phase is between 2n and 4n. 
Following DNA duplication, cells enter a second growth phase called G2, in which 
cells duplicate their infrastructure, including the quantity of ribosomes, ribosomal 
RNA, cellular proteins. and other functional elements in preparation for cell division 
(Wieder, 1999). The G-) gap allows time for the cell to ensure DNA replication is 
complete before initiating mitosis. In mitosis, there are four successive phases called 
prophase. metaphase. anaphase and telophase that are accompanied by cytokinesis 
givincy rise to two daughter cells (Murray and Hunt, 199-33). For the most part, upon L- r_1 r_1 
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completion of the process, each daughter cell contains the same genetic material as 
the original parent cell. In addition to these specific stages, the Go phase has been 
described for cells that exit the cell cycle and enter a quiescent, non-dividing state. In 
response to external stimuli, some quiescent cells may undergo reactivation and 
express early response genes, so that they can leave Go and enter the G, phase of the 
cell cycle. For instance, KI-67 protein is a marker for distinguishing proliferating G, 
from Go cells (Stein and Pardee, 2004). 
In many ways, cancer cells resemble undifferentiated cells, which exhibit similar 
properties during normal embryogenesis. They differ from their normal counterparts 
by their ability to grow, divide and invade, without the normal restraining forces 
operating (Price and Sikora, 2002). Thus, unlike normal cells, which can enter a 
quiescent stage when their numbers reach a certain level (stop dividing by contact 
inhibition), transformed cells or cancer cells, which lose this aspect of growth 
regulation, continue to divide and keep growing until the supply of nutrients or some 
other factor becomes limiting (Pollard and Earnshaw, 2002). 
1.4 Cell death 
Generally, there are two different mechanisms of cell death, apoptosis (programmed 
cell death) and necrosis (accidental cell death). These two types of cell death are 
demonstrated in Figure 1-3. Remarkably, necrosis is the consequence of a passive, 
degenerative process, which is identified primarily by loss of membrane integrity. 
1.4.1 Apoptosis 
It is generally accepted that all cells have the ability to under go an internally 
controlled cell suicide process known as apoptosis, or programmed cell death, in 
response to a given stimulus or environmental agent (Schwartzman and Cidlowski, 
"). The term "apoptosis" itself derives from a Greek word that describes 1991 
phenomena such as the falling of leaves from trees. Apoptosis is a mode of cell death 
that facilitates such fundamental processes as development (for example. removal of 
unwanted tissue during embryogenesis) and the immune response (for example, 
elimination of self-reactive T cells) (Allen et al.. 1993). 
Apoptosis is characterized b\ a distinct set of morphological and biochemical features 
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including cell shrinkage, nuclear condensation, proteolysis, internucleosomal DNA 
cleavage, and apoptotic body fori-nation (Martin et al., 1994). In the process of 
apoptosis, DNA fragmentation involves endonuclease, which characteristically breaks 
the DNA between the clumps of chromatin that are referred to as nucleosomes, the 
consequence of this is that the DNA breaks into fragments of rather precise sizes that 
are multiples of about 200 DNA base pairs in length. Whilst these processes of DNA 
cleavage are going on, the nucleus begins to break into fragments and the cell likewise 
splits into pieces; thus the original dying cell generates a number of cellular apoptotic 
bodies or apoptotic fragments. This used to be referred to as karyorrhexis. Finally, 
these fragments are engulfed by the specialised migrating macrophages or healthy 
neighbouring epithelial cells by a process called phagocytosis. This phagocytic 
process results in apoptotic bodies enclosed in a membrane-bound vesicle in a cell 
called a phagosome (see Figure 1-3). The host cell then gradually digests the 
apoptotic body (Potten and Wilson, 2004). 










2ý P OPT 0`3 1`3 
Fit! ure 1-3: Momhological illustration of apoptosis and necrosis (from 
http: //www. cecs. cl/web/cecs) 
In oncology, the interest in apoptosis originates from the observations that ionizing 
radiation or interactions of antitumour drugs with their respective intracellular targets Z-- II 
often result in this mode of cell death, and that the efficacy of several antitumour 
druos correlates with their ability to induce apoptosis (Kaufmann, 1989, Krishan and Z-- I 
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Frei,, 1975; Szende et al., 1989). The possibility, therefore, of modulating this process 
can open new strategies for improving chemotherapy. In addition, the ability to 
monitor early signs of apoptosis in samples from patient tumours may be predictive 
for the outcome of treatment protocols (Darzynkiewicz et al., 1992). 
1.4.2 Necrosis 
In contrast to apoptosis, or programmed cell death, necrosis is a non-specific mode of 
cell death. It can be caused by excessively high concentrations of toxic agents 
(Lennon et al., 1991). When cells die by an accidental cell death process known as 
necrosis, the cells swell. This cellular swelling is caused by the early loss of energy 
and cell membrane integrity from the cell permitting the movement of both ions, 
mostly sodium, and water into the cell. Necrotic cells eventually lyse, in turn 
triggering an inflammatory response, which is not observed during apoptosis 
(Studzinski, 1999). 
Practically, necrosis can be induced by either physical disruption or severe metabolic 
poisons. It is often characterised by clumps of cells in tissue, where the cells swell 
and the cytoplasmic organelles start to disintegrate very rapidly. Furthermore, the 
DNA in the nucleus condenses, particularly at the margins, in an irregular fashion and 
the DNA and cellular constituents start to disintegrate in a random and uncontrolled 
fashion. Subsequently, vital internal constituents rapidly leak out of the cell and the 
host tissue recognises this and floods the system with inflammatory lymphocytes to 
stop infection and damage to the tissue being induced. The debris is then engulfed and 
removed by macrophages (Kerr and Harmon, 1991; Potten and Wilson, 2004). 
As seen in Table 1-2, apoptosis and necrosis can be distinguished from one another by 




Chapter 1 Introduction 
Apoptosis I Necrosis 
Cell morphology 
Cell shrinks dramatically due to Cell swells and loses integrity of cell 
blebbing and produces apoptotic membrane due to influx of H20 
bodies 
Membranes and organelles remain Outer membrane and organelle 
intact membranes rupture leading to non- 
specific release of damaging enzymes 
like DNAases and proteases 
Nucleus condenses Nucleus swells 
Pyknosis and karyorrhexis (dense Karyolysis preceded by irregular 
condensation of chromatin) chromatin clumping 
DNA degradation 
Apoptosis exhibits intemucleosomal Necrosis exhibits random DNA 
DNA degradation degradation 
Caused by activation of specific Caused by intracellular enzymes 
nucleases released upon organelle membrane 
rupture or caused by random 
interaction with random enzymes 
Inflammatory response 
No inflammatory response because Extensive inflammatory response due 
membranes remain intact to release of intracellular material 
from the necrotic cell 
Synthesis of anti-inflammatory agents Inflammation can further damage 
occurs that results from actual normal tissue 
upregulation of certain apoptotic gene 
products 
Activation of proteases 
Activation of caspases (cysteine Lysosomal rupture leads to release of 
proteases) that specifically cleave many non-specific proteases which 
substrates with aspartic acid residue cause non-specific destruction of cell 
proteins 
Genetic regulation 
Under strict genetic control Induced by harsh cellular environment 
R-P ------------- --L - 
Table 1-2: Comparison of a0 tosis with necrosis summarised from Mattson et al.. 
200 1. Darzynkiewicz et al.. 1994; Shi et al., 1997ý 
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1.5 Cancer treatment 
1.5.1 Surgery 
Surgery is the oldest and most frequently used cancer therapy. It is most efficacious 
in the treatment of local disease in the region of the primary tumour and in regional 
lymphatics. Although surgery is still preferred in a high percentage of cases, it is no 
longer considered as the sole therapy for many neoplasms. Once a neoplasm has 
spread from the primary site to a distant organ, especially multiple metastasis, surgery 
should have little role in management of the disease (Holland et al., 1993). Therefore, 
the use of chemotherapy and radiation therapy in combination with surgery has 
considerably reduced the extent of operation needed to manage many types of cancer. 
1.5.2 Radiation 
In modem decades, radiotherapy has become a standard treatment option for a wide 
range of malignancies. Data from the US Surveillance, Epidemiology, and End 
Results (SEER) program show that radiation treatment is commonly included in 
primary oncological treatment. If subsequent palliative interventions are included, 
more than half of cancer patients receive radiotherapy at least once in their care 
(DeVita et al., 2005). 
1.5.3 ChemotheraPy 
Chemotherapy began in 1946 when nitrogen mustard was used to treat patients with 
lymphoma and leukaemia (Goodman et al., 1946). Over the past 20 years new 
therapies have emerged and innovation in this area is constantly evolving. Nowadays, 
it has become one of the most significant treatment modalities in cancer care. 
Currently there are over 500 molecules in clinical development by 43 pharmaceutical 
companies. It is likely that fewer than 30 will actually make it to the marketplace, and 
fewer than five will make a big impact on cancer care. The high-cost drugs can 
achieve extension of life for patients, however, people have to assess how much they 
are willing to pay for a month of reasonable -quality life (Price and Sikora, 2002). As 
a result. the demand for a cheap source of chemotherapeutic drug with high efficacy is 
still quite higli. Zý 
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Based on cancer cell kinetic data,, it is reasonable to assume that even small turnours, 
when clinically detectable, already have resistant clone(s) of cells (Garrett and 
Workman, 1999). The use of cytotoxic agents of different groups in combination, 
which attack different biochemical targets should give a broader range of cover of 
resistant cell lines in a heterogeneous tumour population (Shah and Schwartz, 2000). 
The development of new resistant cell lines is thus slowed or prevented. thereby 
giving maximum cell kill, which is impossible with a single-agent regimen. 
Therefore, the more novel chemotherapeutic molecules are developed, the higher are 
the chances to eliminate drug-resistant cancer cells. 
1.5.4 Chemoprevention 
New drugs are developed and tested to prevent cancer, in contrast to classical 
chemotherapy for treatment of existing disease. This new pharmacological approach 
to arrest or reverse the process of carcinogenesis, and thus to prevent cancer, is called 
chemoprevention (Sporn and Liby, 2005). It has been shown convincingly that the 
use of chemopreventive agents in men and women with premalignant lesions can 
substantially reduce the subsequent development of truly invasive cancer. 
Chemoprevention is now recognized as both a clinical and basic science (Alberts et 
al. . 1999). 
Carcinogenesis often proceeds through multiple stages, such as initiation, promotion, 
progression, etc. As a result, the transitions between successive stages of 
carcinogenesis can be enhanced or inhibited by various agents. Several types of 
evidence indicate that at least half of human cancer is potentially preventable (Alberts 
el al., 1999). 
Plant foods contain a wide variety of anticancer phytochernicals with many potential 
bioactivities that may reduce cancer susceptibility. Using a panel of in-vitro bioassays 
to monitor chromatographic fractionation, a diverse group of plant secondary 
metabolites has been identified as potential cancer chernopreventive agents from 
mainly edible plants. Flavonoids and isoflavonoids are especially promising 
candidates for cancer prevention (Kinghorn et al., 2004; Birt et al.. 2001). They are 
biosynthesized by plants and have strong antioxidant activity in scavenging free 
radicals which are involved in cell damage and turnour promotion (Mitchell et al., 
1998). At the same time. flavonoids are known to suppress turnour cell growth, which 
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is mediated by different types of cell cycle arrest and induction of apoptosis in several 
tumour cell lines. For instance, genistein, the principal isoflavonoid contained in 
soybeans, is thought to be particularly effective in the prevention of prostate. breast 
and colon cancers (Adlercreutz et al., 1995). 
1.6 Natural products in anticancer treatments 
Generally, the accelerated pace of (aberrant) gene identification, and the new 
technologies of combinatorial. chemistry and high-throughput screening, should 
provide access to a wide range of new, totally synthetic drugs. On the other hand, 
natural products are likely to provide many of the lead structures, and these will be 
used as templates for the construction of novel compounds with enhanced biological 
properties (Mann, 2002). 
Plants have been used as medicine for millennia. Out of estimated 250,000 to 
350,000 plant species identified so far, about 35,000 are used worldwide for medicinal 
purposes (Kong et al., 2003). Its has been confirmed by WHO that herbal medicines 
serve the health needs of about 80 percent of the world's population; especially for 
millions of people in the vast rural areas of developing countries (Anonymous, 2002). 
The search for anticancer agents from plant sources started in earnest in the 1950s 
with the discovery of vinblastine in the Madagascar periwinkle, and the isolation of 
the cytotoxic podophyllotoxins (Cragg and Newman, 2005). It has been estimated 
that in the mid-1990s over 200 companies and research organizations worldwide are 
screening plant and animal compounds for medicinal properties. Especially, the 
National Cancer Institute (NCI) (of the US) initiated an extensive plant collection 
program in 1960, focused mainly in temperate regions, and began to screen plant 
extracts for anticancer activity. This led to the discovery of many novel chemotypes 
showing a range of cytotoxic activities, including the taxoids and camptothecins. 
Natural compounds isolated from medicinal plants, as rich sources of novel anticancer 
drugs, have been of increasing interest since then (Cai et al., 2004). As a result, over 
60% of currently used anticancer agents are derived in one way or another from 
natural sources, including plants. marine organisms and micro-organisms (Newman et 
al., 2003). 
The most efficient method of discovering drugs such as novel anticancer agents is 
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bioactivity-guided fractionation of natural products (Pezzuto, 1997). It is certain that 
more natural product drugs, some of which should be useful for the treatment of 
humans, remain to be discovered. Moreover,, for the commercial procurement of 
structurally complex natural product drugs, isolation from plant material may be most 
practical. There are many well known anticancer drugs which were developed from 
natural products (see Table 1-3). For instance, paclitaxel is now the first drug of 
choice in several cancers including breast cancer. Vinblastine is the first drug of 
choice in many forms of leukemia and since the 1950s it has increased the survival 
rate of childhood leukemias by 80% (Kong et al., 2003). 
Besides those compounds with unusual structure and very high cytotoxicity 
recognized as anticancer agents, a variety of polyphenolic compounds of plant origin 
are known to inhibit cancer (Yang et al., 2001). These compounds are relatively less 
cytotoxic and may affect cancer progression as a result of their effects on cell cycle 
progression, growth, differentiation as well as their antioxidant, apoptotic and 
antiangiogenic effects. 
The antioxidant activities of polyphenols are well recognized and may be responsible 
for various health benefits. Free radicals are produced by pollutants in our food, 
water and air; oxidation-reduction reactions of lipids and metal ions; and continuous 
mitochondrial electron transport reactions in the body (Liu et al., 2002). Catechins in 
green and black tea and red wine can deactivate these aggressive superoxide, alkyl 
and hydroxyl free radicals by providing an electron, thereby preventing attack on 
DNA and other cell components (Brownson et al., 2002). The radicals produce free 
radical chain reactions, which leads potentially to heart disease, stroke, memory loss 
and cancer. In one step, catechins help subvert these health problems by converting 
damaging free radicals to inactive compounds while themselves becoming low-energy 
harmless catechin free radicals. In addition to being powerful antioxidants, catechins 
such as epigallocatechin gallate (EGCG) in green tea absorb ultraviolet light in the 
280-320nm range, preventing the promotion of photoinduced skin cancer. EGCG 
also has substantial inhibitory effects against a wide variety of turnours in vivo and 
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Some isoflavones have been shown to exert antiproliferative effects on cancer cells by 
steroid receptor signalling (Thelen et al.. 2005). Some of these compounds have 
oestrogenic (or antioestrogenic) activity and are commonly referred to as phyto- 
oestrogens. Progression from latent stages into clinically significant cancer is a 
process that generally requires several years. During this period of time dietary 
phytochemical, such as genistein from soy may have chernopreventive effects. which 
could slow or obviate hormone-dependent cancer development (Denis et al., 1999). 
1.7 Traditional Chinese Medicine in anticancer treatment 
Ancient China is a source of information about the early medicinal uses of plants. 
"Ben Cao Gang Mu" (Compendium of Materia Medica), a pharmacopoeia of TCM 
that was actually written in 1578, contained thousands of herbal cures (Kong et al., 
2003). The long tradition of herbal medicine continues to the present day in China. 
As a result, almost 5,000 plants have been used in traditional Chinese medicine 
(Wakdikar, 2004). 
In recently published monographs on anticancer Chinese medicines, more than 400 
Traditional Chinese Medicinal (TCM) species were summarized and documented as 
being associated with anticancer treatment, based on long-term practical experience of 
the use of TCM for anticancer purposes (Cai et al., 2006). The TCMs selected for the 
present study have been recorded to be used for anticancer treatment in China (Ji, 
1999), but have not been investigated very well for their active components with 
bioactivity for anticancer purposes. 
1.7.1 TCMs Investigated 
1.7.1.1 Dolichos lablab L. 
Dolichos lablab L. is a perennial vine belonging to the Fabaceae. It is widely 
cultivated in China. In TCM, the white seeds of Dolichos lablab L. (see Figure 1-4). 
so called "Bai Bian Dou" (Chinese pin yin name), have been prescribed for 
stomachic. antidote and antialcoholism purposes (Yoshikawa et al., 1998). It was 
frequently involved in some complex prescriptions of TCM for treatment of gastric 
cancer. hepatoma and cervical carcinoma (Ji, 1999). 
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It was reported that the glycoside mixture obtained from the white seeds of Dolichos 
lablub L. showed potent adjuvant activity (induction of the antibody response against 
chicken ovalbumin in mice) (Oda el al., 2000). In continuing studies, several saponin 
constituents, such as lablabosides A-C (I - 3) have been isolated from the glycosidic 
fraction with the adjuvant activity (Yoshikawa et al., 1998). Chikusetsusaponin IVa 
(4) and lablabsaponin 1 (5) were also isolated from the seeds. Moreover, 
lablabsaponin 1 (5) exhibited strong superoxide dismutase-like activity on the 
hypoxanthine-XOD system (Yoshiki et al., 1995). 
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1.7.1.2 Gekko swinhonis Gunther 
Gekko swinhonis Gunther is a small vertebrate frequently adapted to human 
habitations, and usually crawls around walls and ceilings at night in search of insects. 
It was introduced as "Bi Hu" (Chinese pin yin name) in --Ben Cao Gana Mu" 6 
(Compendium of Materia Medica) and its dried body (see Figure 1-5) has been used 
as a medicinal material from ancient times (Chen and Huang. 200 1). 
A 1; 1 
I-e 
Figure 1-5: Dry body of Gekko swinhonis Gunther as used as raw medicine 
Gekko s-", inhonis Gunther has been listed in some TCM prescriptions used to treat 
arthritis, carious osteitis and carbuncle. In recent years, it was commonly used to treat 
many kind of cancer, such as nasopharyngeal carcinoma, lymphoma and lung cancer. 
Most clinical trials reported are treatments against gastric carcinoma and hepatoma 
(Chen et al., 1988). More than 28% of patients were cured in a clinical trial 
(involving 118 patients) for two complex prescriptions with Gekko sivinhonis Gunther 
as the major ingredient (Song et al., 1996). To some extent, the lives of patients were 
prolonged and living conditions were improved in most cases of cancer treated by 
Gekko sit, inhonis Gunther (Lu, 1985). 
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Illicium verum Hook-f 
Star anise (see Figure 1-6) is the fruit of 11licium verum Hook. f which is an evergreen 
tree belonging to the Illiciaceae. It is an important spice and a well known TCM used 
in the treatment of stomach ache (Nakamura et a/., 1996). However, it is easily 
confused with the extremely poisonous Illicium anisatum, containing anisatin (6). 
Figure 1-6: Fruit of Illicium verum Hogk. f 
Star anise (the fruit of Illicium verum), known as '*Ba Jiao" in TCM, has been shown 
to possess potent antimicrobial properties effectively against bacteria, yeast and 
fungal strains (De et al., 2002). Further investigation suggested that a major portion 
of this antimicrobial property is due to anethole (7) present in the dried fruit. It is one 
of the major components of the fruit and accounting for 76% of the extracted volatile 
oil (Yan et al., 2002). The butanol extract of star anise showed inhibitory activity 
(IG50=44ýtg/ml) on the tube-like formation induced by human umbilical venous 
endothelial cells in the in-vitro angiogenesis assay (Nam et al., 2003)). That might 
contribute to its anticancer action. Other compounds isolated from Illicium verum 
include 1-(4'-methoxyphenyl)-1,2-propanedioI (8), veranisatin A-C (9,10 and 11), 
verimol C (12), verimol D (13), verimol F (14) and verimol K (15) (Sy and Brown. 
1998). It was reported that veranisatins caused convulsions and showed lethal 
toxicity in mice at a dose of ')mg/kg. They caused hypothermia at lower doses 
(Nakamura et al., 1996). 
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1.7.1.4 Lonicerajaponica Thunb. 
Lonicera japonica Thunb., also known as Japanese honeysuckle, belongs to the 
Caprifoliaceae. Its dry flower buds are known as -Jin Yin Hua- in TCM. It has 
latent-heat-clearing, antipyretic, detoxicant and anti- inflammatory actions, therefore is 
prescribed to treat fever caused by common febrile diseases, dysentery, carbuncles, 
furuncles and infected swellings (Chang and Hsu, 1992; Lee et al., 1998). It is an 
important herb in many complex prescriptions of TCM for treatment of skin cancer, 




Figure 1-7: Dry flower buds of Lonicery japonica Thunb. 
Methyl caffeate (16), -'), 
4-di-O-caffeoylquinic acid (17) and methyl '), 4-di-0- 
caffeoylquinate (18) are polyphenolic compounds isolated from Lonicerajaponica. 
They had exhibited strong inhibitory effect on human platelet aggregation (Chang and 
Hsu, 1992). Other plant phenols found in Lonicerajaponica include chlorogenic acid 
(19), protocatechuic acid (20), chrysin (21), luteolin (22) and rutin (23) (Kumar et al., 
2005). Luteolin (22) has been demonstrated to have an effect on various cancers such 
as human leukemia cells and pancreatic tumour cells (Lee et al., 2002; Ko et al., 
2002). Protocatechuic acid (20) has been showed to be capable of inducing c-Jun N- 
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1.7.1.5 Iris tectorum Maxim. 
Figure 1-8: Iris tectorum Maxim. (blooming on 25 April 2005 in Beijing. China) 
Figure 1-9: Flower of Iris tectorum Maxim. (blooming on 25 April 2005 in Beijing, 
China) 
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Iris tectorum Maxim. belongs to the Iridaceae. It is a perennial herb vvhich is native 
means blue butterfly. It also to China. Its Chinese common name is -= 
known as Japanese Roof Iris in some papers, because that is where it was first 
observed by the Russian botanist, Carl Maximowicz (1827-1891). At that time, 
Japanese people planted it on straw-thatched roof of houses (Klingaman, 2005). The 
distinctive characteristic of its flower is the cockscomb-like frill at the outer petal (as 
shown in Figure 1-9). Iris tectorum has yellowish green leaves emerging directlý' 
from the ground in basal fans, broadly sword-shaped, curved and have no midrib (see 
Figure 1-8). Its rhizome is creeping and thick. Generally, it grows 12- to 18-inches 
tall producing blue flowers in April and May. The favourable environments are forest 
margins, sunny banks, meadows, damp places and beside water; its distribution 
altitude is 500-3,500 meters. It is wide spread in China and easily seen in Anhui, 
Fujian, Gansu, Guangdong, Guangxi, Guizhou, Hainan, Hubei, Hunan, Jiangsu, 
Jiangxi, Qinghai, Shanxi, Sichuan, Xizang, Yunnan and Zhejiang provinces (Zhao et 
al., 2000). 
The rhizome of Iris tectorum (Figure 1-10) was introduced as a medicine in the first 
Chinese monograph of herbal medicines "Shen Nong Ben Cao Jing", which was 
written about two thousand years ago. Where it was introduced as a bitter medicine to 
treat some disorders described as "MMOM" (in ancient Chinese). These syndromes 
are very similar to the descriptions of tumours in modem medical knowledge. It was 
also commonly used as an anti-helminthic TCM in China. In recent years, however, 
this plant is seldom seen in TCM prescription because it is not available in modem 
TCM shops any longer. Actually, Iris tectorum has become a decorative plant in 
gardens and used to beautify the envirom-nent of cities in China. 
The idea of exploring the Iris tectorum -derived compounds as anticancer drug is 
rather new. The rhizome of Iris tectorum Maxim. has been used as herbal medicine in 
China for thousands of years, however, it was usually used as a substitution of 
Belamcanda chinensis in some area of China (Xiao et al., 2002). According to the 
latest edition of Chinese Pharmacopoeia (Anonymous, 2005). it is referred as -Chuan 
She Gan", used to treat sore throat, disperse phlegm, heat-clearing and detoxicating. 
It was also recorded to treat abdominal distension and hepatic cirrhosis (Song et al. . 
2001) in China. In Japan it is used as an emetic and a laxati\, e (Seki et al., 1994). A 
field study and investigation in the present study revealed that the rhizome of Iris 
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tectorum has been used as traditional folk medicine for the treatment of cancer in 
Tongren, a small town in Guizhou province, South China. 




Fil4ure 1-10: Dry rhizome of Iris tectorum (cut into pieces) as raw TCM 
The major compounds in the root of Iris tectorum are tectorigenin (24), tectoridin (25) 
and irigenin (26) (Wu and Xu, 1992). Other compounds isolated from Iris tectorum 
include the flavonoids, iristectorigenin A (27), iristectorigenin B (28), iristectorin A 
(29) and iristectorin B (30) (Morita et al., 1972), and the terpenolds: iridotectoral A 
(3 1) and iridotectoral B (32), (6R, I OS, II R)-26-4-hydroxy-(l 3R)-oxaspiroirid- I 6-enal 
(33) and 28-deacetyl-belamcandal (34) (Takahashi et al., 2000). Further investigation 
lead to the isolation of seven triterpene esters, named iristectorenes A-G (35 - 41) 
(Seki et al., 1994) and eight tetracyclic esters, named iristectorones A-H (42 - 49) 
(Seki et al., 1994a) from the seed oil of Iris tectorum. 
28-Deacetybelamcandal (34) was isolated from a methanolic extract of the rhizomes 
of Iris tectorum and demonstrated as a turnour-promoting triterpenoid with activation 
of protein kinase C and induction of TNF-a. release from HL-60 cells (human 
promyelocytic leukemia) (Takahashi et al., 1999). 
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R 
35: R= CO(CH2)7CHc-'sCH(CH2)3Me 
36: R= CO(CH2)12Me 
37: R= is CO(CH2)gCH=cCH(CH2)3Me 
38: R= CO(CH2)7CH=C cis HCH2C Hc'sC H (C H2)4Me 
39: R= CO(CH2)14Me 
40: R= is CO(CH2)9CH=cCH(CH2)5Me 







43: R2 = CO(CH2)12Me 
44: R2 = CO(CH2)gCH= c'sCH(CH2)3Me 
45: R2 cis C's = CO(CH2)7CH=CHCH2CH=CH(CH2)4Me 
46: R2 = CO(CH2)14Me 
47: R2 = CO(CH2)gCHc=isCH(CH2)5Me 
48: R2 is = CO(CH2)1 CHc=CH(CH2)3Me 
49: R2 = CO(CH2)16Me 
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1.8 Positive controls in bioassays 
1.8.1 Luteolin (22) 
Luteolin (22), a dietary flavonold with high antioxidant activity (Lee et al.. 1995), 
commonly found in some medicinal plants, usually occurs as glycosylated fon-ns in 
celery, green pepper, perilla leaf and camomile tea, etc., and as an aglycone in perilla 
seeds (Ko et al., 2002; Shi et al., 2005). It has been reported to exhibit anti- 
inflammatory activity (Harris et al., 2006) as well. 
Previous research work had demonstrated that luteolin (22) inhibited tumour growth 
and angiogenesis in a murine xenograft model (Bagli et al., 2004). Also, it inhibited 
vascular endothelial growth factor (VEGF)-induced in-vivo angiogenesis in the rabbit 
corneal assay. Those results might explain the protective action of plant-based diets 
on the incidence of cancer. 
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Moreover, it has shown inhibition of proliferation as well as apoptotic effect on 
various cancers such as a human leukaemia cell line and pancreatic tumour cells (Ko 
et al., 2002; Lee et al., 2002). Several reports suggested that luteolin (22) is an 
inhibitor of topoisomerase I and 11 (Chowdhury et al., 2002; Webb and Ebeler, 2003)). 
Furthermore, a recent study revealed that the apoptosis induced by luteolin (22) is 
mediated through death receptor 5 (DR5) up-regulation (Horinaka et al., 2005). 
These results further support its therapeutic potential as a lead anticancer compound. 
Thereby, luteolin (22) was employed as a cytotoxic flavonoid aglycone of luteolin-7- 
0-. (Ylucoside (50) for the establishment of prodrucy assay in the present study. Z__ tý 
OH 0 OH 
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1.8.2 Genistein (5 1) 
Genistein (4', 5,7-trihydroxylsoflavone) (51) was selected as a positive control for 
apoptosis assays in present study. Genistein (51), as a natural product, has been 
identified as having anti -proliferative and apoptotic effects on various malignant cell 
types derived from solid turnours (Park et al., 2005; Yu et al., 2004). Epidemiological 
studies have shown a lower incidence of breast, prostate, and colon cancers in Asian 
countries, particularly China and Japan, than in the United States. Therefore, it is 
believed that a diet rich in isoflavonoids may play an important role in cancer 
prevention (Messina et al., 1994; Markovits et al., 1989). As a isoflavone, genistein 
(51) is believed to be a metabolite of soy produced by the gut floral bacteria 
(Adlercreutz et al., 1995). Studies of the effects of genistein (51) against different 
types of malignant cells have been carried out in both in vitro and in vivo experiments 
(Polkowski and Mazurek, 2000). A number of studies have shown that genistein (51) 
induced cell cycle progression arrest at the G2/Mphase and induced apoptosis in 
leukaerma, breast, gastric, colon and prostate cancer cell lines (Traganos et al., 1992; 
Hotz et al., 1992; Pagliacci et al., 1994; Matsukawa et al., 19933; Kyle et al., 1997). 
In addition, apoptosis was induced by lower concentrations of genistein whilst 
necrosis was induced by higher concentrations of genistein in TM4 testis cells for 12h 




1.8.2.1 Tyrosine kinase inhibition effect 
The mechanisms of anticancer effects of genistein were also investigated in previous 
studies. It was suggested to be a potent inhibitor of epidermal growth factor receptor. 
a tyrosine-specific protein kinase (Akiyama et al., 1987; Linassier et al., 1990, 
Spinozzi et al.. 1994). Epiden-nal growth factor (EGF) is a key driver for cell growth. 
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Moreover, tyrosine kinase receptors for EGF has been widely implicated in promoting 
proliferation and progression of malignant cells including those of the lung, breast, 
prostate, colon, ovary, head and neck. Consequently, these receptors and their 
signalling pathways are targets for the development of novel anticancer therapies 
(Wells, 2000). 
1.8.2.2 Topoisomerase 11 inhibition effect 
A multitude of studies revealed that genistein inhibits DNA topoisomerases 11 in Otro 
(Markovits et al., 1989; Ding et al., 2001; Salti et al., 2000; McCabe and Orrenius, 
1993). A possible mechanism of induction of apoptosis is through either stabilization 
of DNA topoisomerase 11 complexes consequently blocking DNA religation or 
blocking the enzyme's catalytic activity (Beck et al., 2001). Topoisomerase 11 first 
interacts with DNA by reversibly forming a noncovalent complex. At this stage no 
DNA strand breaks have been made and, because abrupt removal of the enzyme 
would leave no residual damage, this initial complex is termed "'noncleavable". The 
enzyme then cuts both DNA strands, forming a covalent bond between each protein 
subunit and one of the newly formed 5'-phosphate ends of the DNA. This complex is 
considered "cleavable"', since removal or disruption of the protein would result in a 
permanent double-strand break. In the absence of inhibitors the cleavable complex is 
either rapidly converted back to the noncleavable complex or, after accomplishing a 
topological change by strand passage or rotation, the breaks are resealed and the 
enzyme dissociates from the DNA. Inhibitors stabilize the cleavable complex, 
preventing it from going back to the noncleavable complex or from completing strand 
passage or rotation (Pratt, 1994). 
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1.8.3 Vinblastine (52) 
Vinblastine (52) is an alkaloid which was isolated from the periwinkle plant 
Catharunthus roseus (previously known as Vinca rosea). Initially, extracts of 
Catharanthus roseus were investigated because it was reputed to be useful in the 
treatment of diabetes, however, it led to the discovery and isolation of two complex 
indole alkaloids, vinblastine and vincristine, which have been used in the clinical 
treatment of a variety of cancers (Noble, 1990). The so called -vinca alkaloids", 
including vinblastine (52), vincristine (53), vindesine (54) and vinorelbine (55) 
(semisynthetic derivatives of vinblastine) have become clinically useful since the 
discovery of their antiturnour properties in 1958 (Fox, 1991; Zhou and Rahmani, 1992, 
Curran and Plosker, 2002). 
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Further study revealed that vinblastine (52) is a cell cycle-specific agent, which arrests 
many mammalian cells in metaphase of mitosis by an action on microtubules (Toso et 
al. ý 1993). Thus, vinblastine sulphate (69) was used as a positive control 
for in-11tro 
bioassays in present study. 
1.8.3.1 Microtubule inhibition effect 
The central function of mitosis is to segregate the two sets of chromosomes that are 
present in the cell after S phase. Chromosome segregation is carried out by the 
mitotic spindle, which pulls the sister chromatids apart and moves a complete set of 
chromosomes to each pole of the cell, where they are packaged into daughter nuclei. 
The mitotic spindle is based on a bipolar array of microtubules, which are highly 
dynamic polymers that continuously grow and shrink, the major component of 
microtubules is tubulin (Jordan, 2002; Scholey et al., 2003). Vinca alkaloids bind 
specifically to free tubulin dimmers. Once bound to Vinca alkaloids, tubulin dimers 
are unable to aggregate to form microtubles. This effectively decreases the pool of 
free tubulin dimers available for microtubule assembly. The effect of disrupting the 
balance between microtubule polymerization and depolymerization results in the net 
dissolution of microtubules, destruction of the mitotic spindle and arrest of cell in 
metaphase (Wilson et al., 1975). 
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CHAPTER 2 
PHYTOCHEMICAL INVESTIGATION 
2.1 General techniques and materials 
The TCM samples: Dolichos lablab L., Gekko swinhonis Gunther and Lonicera 
japonica Thunb. were obtained from Tong Ren Tang herbal shop in Beijing. Illicium 
verum Hook. f was kindly donated by Natural Product Research group in Royal 
Botanic Gardens, Kew. Iris tectorum Maxim. was obtained from a local herbal shop 
in Tongren (a town in Guizhou province, China). All TCM samples were 
authenticated by staff in Royal Botanic Gardens, Kew. Reference samples are 
deposited in the collection of the Pharmacy Department, King's College London. The 
record of vouchers is summarized in Table 2-1. 
A limited amount of the TCMs were firstly extracted with four solvents (hexane, 
CHC13, ) MeOH and water) in a Soxhlet apparatus, each extract was obtained by ten- 
cycle extraction (see Figure 2-1). Afterwards, the crude extracts were subject to 
primary screening for inhibition against cancer cells. All solvents were from BDH 
Supplies, UK, and chemicals and medium were from Sigma-Aldrich, UK, unless 
otherwise indicated. 
Plant name Date Part used Voucher No. 
Dolichos lablab L. Jan. 2003 Seed D021-KI 
Gekko swinhonis Gunther Jan. 2003 Dry body GElOl-EI 
Iris tectorum Maxim. July 2004 Rhizome TCMK 598* 
Illicium verum Hook. f Dec. 2002 Fruit IL22-L9 
Lonicerajaponica Thunb. Jan. 2003 Flower bud L041 -J I 
Table 2-1: Voucher record of TCM materials used in the -present study (* Voucher No. 
of Iris tectorum Maxim. reserved in the Kew Herbarium. ) 
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Dried and ground TCM material 25g 
Extraction with hexane 
Dry residue 1 11 Hexane Extract 
Extraction with CHC13 
Dry residue 1 11 CHCI-, Extract 
Extraction with MeOH 
Dry residue 1 11 MeOH Extract 
Extraction with H-)O 
Dry residue 1 11 H20 Extract 
Fillure 2-1: Extraction procedure for preliminary screening. (A Soxhlet apparatus was 
used for all extractions) 
2.1.1 Thin-layer Chromatography (TLC) 
Analytical TLC: 
Pre-coated aluminium backed plates of Silica Gel 60 F254 (0.25mm thickness) were 
obtained from Merck Ltd., Magna Park, UK. 
Preparative TLC: 
Silica gel 60 PF254 (Merck Ltd, Magna Park, UK), Imm thick, made on glasses 
(20x'-? Ocm), dried at 105'C for 6 hours before use. Zones on the developed TLC 
plates were observed and marked with a pencil under UV, then scraped off, eluted 
with solvent, filtered and fractions evaporated to dryness under reduced pressure. 
Mobile phases of TLC: 
DSI= CHC13: EtOAc: MeOH (6: 3: 1) 
DS2= CH2021 : EtOH (22: 3) 
Detection: The zones were detected under UV (at 254nm and -3366nm) or 
by spraying 
with acidic anisaldehyde reagent (Gibbons and Gray, 1998). Z-- 
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2.1.2 Vacuum Liquid Chromatography (VLC) 
VLC column was packed by putting silica gel 60 PF254saturated with the initial eluant, 
in a glass Buchner funnel attached to a conical flask with the side arm connected to 
vacuum supply. The sample was reconstituted in a small amount of desirable solvent. 
mixed with some silica gel 60 PF254 (I : I, w/w), then ground in a mortar and allowed 
to dry. The silica-coated sample was applied to the top of the VLC column, and after 
the sample was adsorbed on the top of the column, eluant was added in a fixed 
volume in order of increasing polarity. 
2.1.3 High Performance Liquid Chromatography (HPLC) 
" HPLC equipment: Hewlett Packard 1090 HPLC (Diode Array detector). 
" Analytical HPLC column: ACE8 C-18 (particle size 5ýtm, lengthxl. D.: 
150mmx4mm) 
" Semi -Preparative HPLC column: DiscoveryS HS C18 (particle size 5ýtm, 
lengthxl. D.: 250mmx I Omm) obtained from Sigma-Aldrich (Cat. 568533-U). 
" HPLC grade solvents (acetonitrile and water) were obtained from Fisher 
Scientific UK. 
2.1.4 Infrared Spectroscopy (IR) 
The infrared spectra of isolated compounds were measured with a Perkin Elmer 
Spectrum Ones FT-IR spectrometer with diamond attenuated total reflectance (DATR) 
technique. It allows collection of good-quality infrared spectra from virtually any 
solid or liquid sample with almost no sample preparation. In addition, due to the 
small size of the detection interface on the diamond crystal, the amount of sample 
required is quite small compared to other infrared spectrometers. 
2.1.5 Ultraviolet and circular dichroism spectroscopy 
UV/CD spectra of isolated compounds were obtained on a Jasco J720 
spectrpolarimeter. Samples were prepared as MeCN solutions, and scanned in a 
rectangular cell of pathlength I mm over the region 420 - 180nm. 
2.1.6 Optical rotation 
Perkin-Elmer 141 polarimeter. Sodium D line (589nm) was used for the measurement 
of optical rotation. Samples Nvere prepared as CH-)C12 solution and detected in a 
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cylindrical cell of pathlenth 10cm. 
2.1.7 Mass spectrometry 
Low resolution EIMS was measured on a JEOL JMS-AX505W double Focusing mass 
spectrometer; low resolution ESIMS was measured on a Waters QT6F mass 
spectrometer and high resolution ESIMS (HRESIMS) were measured on a Bruker 
Apex III FT, ion cyclotron resonance mass spectrometer in the department of 
chemistry, King's College London. 
2.1.8 NMR spectroscopy 
1H and 13 C NMR spectra were measured on a Bruker DRX500 (50OMHz) NMR 
spectrometer in CDC13 or DMSO-d6 using TMS as internal standard. (50OMHz for lH 
and 125 MHz for 13C) in the department of chemistry, King's College London. 
2.2 Cell culture and cytotoxicity test 
Cytotoxicity testing in microplates has been widely used for in-vitro anticancer 
screening. The endpoint can be determined by a variety of colorimetric staining 
procedures including trypan blue, crystal violet, neutral red and MTT assay. Using 
these assays, a large number of tests can be carried out in a rapid and automated 
fashion. Most cell viability tests rely on a breakdown in membrane integrity that is 
determined by the uptake of a dye to which the cell is normally impermeable (e. g., 
trypan blue) or the release of a dye normally taken up and retained by viable cells 
(e. g., neutral red). However, this effect does not always predict ultimate survival 
(Freshney, 2000). Many of these techniques are labour intensive with long processing 
time, some are subject to artifacts and sensitive to incubation time, which result in 
poor reproducibility (Fricker, 1994). 
The development of the sulphorhodamine B (SRB) (56) protein staining assay for the 
in-vitro measurement of cellular protein content of adherent and suspension cultures 
was established by Skehan et al. in 1990; subsequently it has been adopted for routine 
use of in-vitro antitumour screening in the National Cancer Institute since 1990 
(Skehan et al., 1990). Sulphorhodamine B (56) is a bright pink aminoxanthene dye 
xvith two sulphonic groups. In mildly acidic conditions, it binds to basic amino acids 
of residues of TCA-fixed proteins. Thus, colorimetric measurement of the bound dve 
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provides a sensitive index of cell protein that is linear with cell number over a cell 
density range of more than 100-fold (Monks et al., 1991). ComparIng with other 
protein and biomass stains, it provides the best combination of staining intensity and 
signal-to-noise ratio in microtitre assays (Skehan et al., 1990). The SRB assay has a 
number of advantages including better linearity, higher sensitivity, a stable end-point 
that dose not require time-sensitive measurement and lower cost (Rubinstein et al.. 
1990). These features make it applicable to large-scale screenings of anticancer druc) ltý 
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2.2.1 Harvesting cells 
1. Cells were incubated in appropriate culture medium at 37'C in 5%CO2 until 
75% confluent. 
2+_, 2+-f 
-buffered saline (PBS) Cells were rinsed with 5ml Ca Mg ree phosphate 
and aspirated. 
3. Cells were subjected to incubation with 2ml 0.05% trypsin/0.5mM EDTA for') 
minutes at ') TC. 
4. Cell culture flask was tapped on the edge with horizontal force until the cells 
detached. If necessary, the flask was incubated for an additional I min, so 
allowing the cells to be detached completely. L- 
5. The detached cells were triturated with aI ml pipette several ti Isr-upt imes to di 
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cell clumps and produce a single cell suspension. 
6.5ml medium containing 10% foetal bovine ser-urn was added to inactivate the 
trypsin. 
7. The cell suspension was transfered to a 15ml conical tube and centrifuged at 
1,500 rpm for 5min, then the cells were resuspended in culture medium or 
PBS as appropriate. 
2.2.2 Seeding density 
Seeding density was chosen according to the cell cycle time determined individually 
for each cell line. For assays over 3-5 days, 5x 103 cells per well in 96-well plate is 
appropriate for all cell lines (as described on page 57). 
2.2.3 Preincubation and dissociation 
Chemical and enzymatic dissociation are traumatic processes that certainly kill some 
cells, meanwhile, sensitizing survivors to other toxic insults. As a result, this 
sensitization can produce false-positive artifacts when cells are subsequently exposed 
to growth inhibitors or cytotoxins. Thereby, dissociated cells require a recovery 
period before an experiment is started. Normally, one day preincubation was found to 
be sufficient (Monks et al., 1991). 
2.2.4 Drug solubilization 
Stock solutions of polar compounds were made in dimethyl sulphoxide (DMSO), then 
diluted in total growth medium to appropriate concentration. All stock solutions were 
sterilized by filtration (0.22[tm pore size). 
Preliminary experiments determined that the toxicity-threshold concentrations of 
DMSO for tested cell lines were in the range of 0.5 - 1%. 1% DMSO in culture 
medium can result in up to 10% inhibition of cell proliferation. Thus, the final 
concentration of DMSO in cell culture experiments was no more than 0.5%. 
1.1.5 Cell fixation 
Trichloroacetic acid (TCA) was the fixative for SRB assay. It fixes cells instantly, 
permeabilizes their membranes so allowing rapid penetration of dve. and great 




2.2.6 Human cell lines 
Four cell lines (COR-L23, C32, MCF-7 and MRC-5) used in this project were 
purchased from the European Collection of Cell Cultures (ECACC). Hepatocellular 
carcinoma (HepG2) was obtained from American Type Culture Collection (ATCC). 
16HBE14o- was kindly donated by Dr Ben Forbes (Department of Pharmacy, King's 
College London) (see Table 2-2). 
All cells cultured with appropriate medium and supplemented with 10% foetal bovine 
serum (FBS), 1% penicillin (104U/ml)/streptomycin (10mg/ml) and 1% L-glutamine 
(200mM). Biochemical agents were purchased from Sigma-Aldrich unless specified. 
At about 70-80% confluence, cells were trypsinised to form a cell suspension and 
counted using a haernocytometer before inoculation. Cells were plated in 96-well 
plate (Costar, 3359) or 6-well plate (Costar, 3516) at appropriate density which 
ensured that the cells were in exponential growth (as described in Figure 2-2 and 
Figure 2-3) and left to attach for 24 hours prior to addition of extract or compound. 
Cell lines Description ECACC No. Medium 
COR-L23 Human non-small cell lung cancer 92031919 RPMI- 1640 
C32 Human amelanotic melanoma 87090201 DMEM 
HepG2 Hepatocellular carcinoma HB-8065 EMEM 
MCF-7 Human Caucasian breast 
adenocarcinorna 
86012803 EMEM 
MRC-5 Human foetal lung fibroblast* 84101801 DMEM 




Table 2-2: Six cell lines employed in bioassays (* Normal cell lines) 
2.2.7 Doubling time determination 
In order to investigate the doubling time (total cell cycle time) for each cell line used 
in the present project, cells were seeded into 96-well plates over a range from 1 X103 
cells/well to 7x 103 cells/well and incubated for 5 days (120h). The growth curve of 
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cells in exponential proliferation is S-shaped when plotted on linear co-ordinates (see 
Figure 2-2) and linear when plotted on semi-log coordinates (the log of cell number vs 
time on a linear scale as shown in Figure 2-3). 
General formula that describes the growth of cells is: 
A =Ao2T' 
T' 
Where A is the number of cells at any time, AO is the number of cells at an initial point. 
T is the time elapsed and T, is the doubling time of the cell. Thus the proliferation 
fonnula can be written as (Wieder, 1999): 
T, = 0.3 T/ log(AIA 0) 
As shown in Table 2-3, the total cell cycle time is determined between two time points 
(day 0 and day 5) where the shape of the growth curve on the semi-log plot is a 
straight line (see Figure 2-3). This exponential part of the growth curve represents the 
time when,, in principle, nearly all of the cells are dividing. 
Obviously, the higher seeding density results in a shorter doubling time, which means 
cells proliferate more quickly to an appropriate density. For example, COR-L23 and 
HepG2 exhibit doubling time of 150h and 108h, respectively, at the seeding density of 
IX 103 cells/well. However, when they were incubated at 7x 103 cells/well, their 
corresponding doubling time dropped down to 41h and 30h respectively (see Table 
2-3). As shown in Figure 2-2 and Figure 2-3 ), cell seeding at 5x 103 and 7x 103 
cells/well exhibited exponential proliferation, and led to a reasonable cell cycle time 
(<48h) for use in the bioassays in the present study. In addition to contact inhibition, 
cells growing at a high density, exhaust nutrients much more quickly than in moderate 
density. In addition, the capability of the cell culture plate and the cost of the growing 
medium and supplements also limit the applicable cell seeding density. 
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Seeding Optical density Doubling Cell lines 
density Day 0 Day 5 time (hours) 
3 1XIO 0.01±0.001 0.02±0.002 150 
3x 103 0.04±0.002 0.13±0.004 66 
COR-L23 
5x 103 0.06±0.001 0-38±0.001 45 
7x 103 0.09±0.002 0.64±0.000 41 
1x 103 0.02±0.001 0.05±0.001 67 
3x 103 0.04±0.000 0.21±0.004 51 
C32 
5x 103 0.08±0.005 0.42±0.002 48 
7x 103 0.08±0.006 0.59±0.020 42 
1x 103 0.01±0.001 0.02±0.001 108 
3x 103 0.03 ±0.000 0.13±0.012 52 HepG2 
5x 103 0.04±0.001 0.49±0.029 34 
7x 103 0.06±0.003 1.00±0.024 30 
1x 103 0.01 ±0.002 0.05±0.002 59 
103 3x 0.03 ±0.002 0.23±0.008 4) MCF-7 103 5x 0.06±0.007 0.54±0.008 38 
7x 103 0.08 ±0.003 0.77±0.005 36 
1x 103 0.01±0.001 0.02±0.002 82 
3x 103 0.02±0.001 0.12±0.003 41 
MRC-5 
5x 103 0.03 ±0.003 0.26±0.003 36 
7x 103 0.04±0.001 0.38±0.001 36 
Table 2-3: Determination of doubling time of five cell lines (n=2, mean±SEM) 
There are two criteria to be considered for the selection of preferred cell density. First, 
all cell lines in control must be keep in the exponential growth phase over the 
incubation time of bioassays. On the other hand, the doubling time (total cell cycle 
time) must be shorter or equal to the incubation time for some bioassays, otherwise a 
cell cycle-specific effect may not be observed. In the present study, 48h was used for 
the incubation time,, in common with most bioassay protocols. The optimized cell 
seeding density for all cell lines was thus 5x 103 cells/well. 
2.2.8 Sample preparation 
40mg extract sample was dissolved in Iml of dimethyl sulphoxide (DMSO) and 
sterilized through a 0.22ýtm pore size filter, and kept at -200C as stock solutions of 
40mg/ml. On the day of inoculation, the testing solutions were made by dilution of 
the stocks. Each extract was prepared in 6 concentrations: 200ýtg/rnl. I 00ýtg/mj. 
57 
Chapter 2 PhNiochemical investigation 
50[tg/ml, 10ýtg/ml, 2ýtg/ml and 0-4ýtg/ml. After adding the sample solutions to test 
plates and mixing with 100ýtl growth medium per well, the testing concentrations in 
the wells were thus: 100ýtg/ml, 50ýtg/ml, 25ýtg/ml, 5ýtg/ml, I ýtg/ml and 0.2ýtg/ml. The 
final testing concentrations of pure compounds were prepared at molar concentrations 
([tM or nM). 
2.2.9 Sulphorhodamine B assay (protocol) 
1. Cells were incubated with the samples for 48h, after which the cells were fixed 
with ice-cold 40% (w/v) trichloroacetic acid (TCA) for I hour at 4'C. Then 
the plates were washed 5 times in distilled water and allowed to dry in the air. 
2.0.4% (w/v) of SRB (Sigma-Aldrich, S1402) solution was prepared in 1% 
acetic acid. This pink solution was added to the dry 96-well plates at 
50ýtl/well and allowed to stain at room temperature for 30 minutes. 
3. After removal of the SRB solution, the plates were quickly washed with 1% 
acetic acid,, 5 times,, to remove unbound dye. 
4. The washed plates were dried in the air. Total protein produced by the cells 
was stained pink. 
5. Bound SRB was solubilized by adding 100ýtl of I OmM unbuffered Tris Base 
(pH 10.5) to each well and shaking for 5min on a shaker platfon-n. 
The plates were read in a 96-well plate reader (SpectraMax-190, Molecular Devices, 
Sunnydale, USA), the working wavelength was 492nm (Keawpradub et al., 1999). 
As a result,, the optical density (OD) of SRB was directly proportional to the cell 
number. 
The results of primary screening are shown as percentage of the remaining cells and 
the cytotoxic activity of potent compounds are indicated by IG50 (growth inhibition of 
50%). There are three required measurements: the OD of the treated cells (T), OD of 
control cells (() and OD of cells at time zero (To), which is from a reference plate of 
inoculated cells fixed with TCA prior to drug addition to the test plates. Data are 
expressed in terms of percentage of remaining cells [(TIC)xIOO], as a measure of cell 
x'iability and survival in the presence of the extracts. For pure compounds and 
standard positive controls, their acti,, 'ity is shown as IG50, which is the drug 
concentration causing a 50% reduction in the net protein increase in control cells 
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[I 00, ý (T-To)I(C-TO)] during the drug incubation (Monks et al., 199 1). 
Data was analysed by using -Analysing Dose-Response Data" in GraphPad Prism 
version 4.00 for Windows to obtain values of IG50. Firstly, the values of optical 
density (OD) were normalized as the percentage of proliferation of tested cells 
comparing with control. Then, the values of concentrations were transformed to their 
respective logarithms using X=Log(X). These manipulations were required to 
produce a conventional dose-response graph with response values plotted against the 
logarithm of drug concentration. At the same time, IG_50 was determined by means of 
"Nonlinear Regression (Curve Fit)". As an example, typical results are shown in 
Figure 2-4. The cytotoxicity against MCF-7 cells of a active compound **A" isolated 
later was 4 times higher than that of another less toxic compound **B" and their dose- 
response regression curves were also remarkably different. 
Proliferation 
125- 











Fiaure 2-4: Dose-res-ponse curves of illustrative examples of isolated compounds 
against MCF-7 cells 
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2.2.10 Optimization of cytotoxicity assay 
Genistein (51) was prepared in solutions over a range of 12.5ýtM to 400pM and 
incubated with COR-1_23 cells (5 x 103 cells/well) for 24h and 48h. As shown in 
Figure 2-5, higher doses and longer treatment times resulted in stronger inhibition 
effect on cell proliferation. 61% cells survived in the first 24h treatment with 400ýtM 
genistein (51), however, the proportion decreased to 25% when the exposure time has 
extended to 48h. Because COR-L23 cell line has a doubling time of 45h and 
genistein (51) is a cell cycle-specific (G2/M phase) agent, insufficient exposure time 
may result in some cells (in a different cell cycle phase) avoiding attack of the cell 
cycle-specific cytotoxic agent. The remarkably different results between the 24h and 
48h treatments clearly suggested that the shorter exposure time (less than that for one 
cell cycle) may lead to an inaccurate cytotoxicity evaluation. So, in the present work, 










11 24h treatment 
Ctrl 12.5 25 50 100 200 400 
Concentration (pM) 
FilZure 2-5: Time-dependent and dose-dependent cytotoxicity of genistein (51) against 
COR-L23 cells (n=2) 
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2.3 Results of the preliminary screening 
The aim of preliminary screening was to select the most active extracts from the 
initial 18 extracts of the organisms tested. The extracts were firstly dissolved in 
DMSO to produce 40mg/ml stock solutions, and then diluted with medium to obtain 
the desired concentrations. All extracts were tested at I 00ýtg/rnl and tested against 
COR-L23, C32, MCF-7, and HepG2 cell lines. Cells were exposed to crude extracts 
for 48h. As shown on Table 2-4, active extracts inhibit proliferation of cells. 
Pl t d 
Remaining cells(%) ±SEM 
an s an extracts 
COR-L23 C32 MCF-7 HepG2 
Hexane 105±1.8 118±5.0 102±2.4 155±5.1 
Dolichos lablab L. CHC13 116±1.9 106±3.4 110±1.9 185±8. ' 3 
MeOH 103±0.8 113±0.2 101±5.2 160±1.0 
H20 118±1.5 118±4.5 107±1.8 205±4.1 
Hexane 90±2.2 118±3.4 92±6.4 146±4.3 
Gekko swinhonis Gunther CHC13 101±1.6 103±0.6 99±3.5 195±10.3 
MeOH 86±4.4 107±0.8 93±4.4 211±32.5 
H20 101±0.5 111±1.1 103±2.1 148±1.9 
Hexane 
Iris tectorum Maxim. CHC13 7±0.7 27±1.5 16±0.5 12±0.9 
MeOH 86±0.8 103±1.1 92±0.6 163±15.2 
H20 101±1.3 109±0.1 97±1.1 141±5.0 
Hexane 11±0.5 86±2.6 14±1.3 130±5.8 
Illicium verum Hook. f CHC13 8±0.3 63±15.2 9±5.4 79±2.0 
MeOH 85±0.9 101±2.3 83±9.4 142±2.3 
H20 91±0.1 103±1.2 90±3.3 103±0.7 
Hexane 
Lonicerajaponica Thunb. CHC13 10±1.4 68±2.3 13±7.6 88±7.0 
MeOH 36±1.2 92±1.0 41±2.1 209±35.1 
H-)O 93±2.3 112±0.1 91±4.1 128±4.1 
Table 2-4: Percentage of remaining cells of four cancer cell lines after exposure to 
plant extracts at I OOvg/ml for 48h (n=3. mean±SEM) 
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Those extracts which caused the proportion of remaining cells lower than 50% 'ýN-ere 
considered to be active and worth following by further bioassay-guided isolation and 
purification. As shown in Table 2-4, CHC13 extracts of Iris tectorum Maxim., Illicillm 
verum Hook. f and Lonicera japonica Thunb. showed considerable cytotoxicity 
against cancer cells. In particular, the CHC13 extract of Iris tectorum Maxim. ,, N-as the 
most active one against all types of cancer cell lines. The other two TCMs were only 
active against C32 and MCF-7 cell lines. Because of the limited time and financial 
support for present study, only the most active extract was selected for further work. 
Therefore,, only Iris tectorum Maxim. was subjected to further phytochimcal 
investigation and bioassays. 
2.4 Phytochemical investigation of Iris tectorum Maxim. 
2.4.1 Bi oactiv ity- directed fractionation 
Results from the preliminary assay for cytotoxic activity indicated promising active 
constituents included in CHC13 extract of Iris tectorum Maxim. A large scale 
fractionation and isolation for the active compounds from Iris tectorum Maxim. was 
carried out and described in Figure 2-6. 
Firstly, 2kg of powdered rhizome was extracted by supercritical fluid extraction (with 
liquidC02) in Shenzhen Neptunus Bioengineering Co. Ltd., China. In this step most 
volatile components that could be extracted into hexane were removed. This was 
confirmed by analytical TLC shown as Figure 2-7. The dry residue was exhaustively 
extracted with CHC13 by Soxhlet extraction for 3 times. The CHC13 extract was taken 
to dryness under reduced pressure, yielding 152g of dried extract. 
In further cytotoxicity assay the chloroform extract of Iris tectorum Maxim. showed 
cytotoxicity against lung cancer (CORL-23) and breast cancer (MCF-7) cell lines, 
with 1&0 values of 36.9ýtg/ml and 35.6pg/ml respectively. However, human 
melanotic melanoma (C32) was less sensitive to this extract and showed an IG7'o of 
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Figure 2-7: Comparison of hexane extract (Hex) with volatile fraction removed by 
supercritical fluid extraction (CO 
-) 
on analytical TLC developed in mobile phase DS I 







Figure 2-8: Percentage of remaining cells of three cancer cell lines after exposure to 
various concentrations of CHC13 extract of Iris tectorum (mean±SEM, n=2) 
1.4.2 Localization of active compounds 2 
An analytical TLC system was established for monitoring separation of the 
compounds in CHC13 extract as displayed in Fi: c: -,, ure 2-9. The four distinguishable 
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zones (PTI - PT4) were collected from 12 preparative TLC plates. which were 
developed in the same mobile phase system (DSI). Then these four sub-fractlons 
were tested for cytotoxicity against cancer cell lines. Figure 2-10 indicates the 
fraction PT2 contains a group of cytotoxic components (Rf = 0.33 - 0.4 on the TLC 
plate in Figure 2-9) in the CHC13 extract. 
-01 -- ------------------------------------------ 4- so I vent 
front 
4- hasel i ne 
PT PTI PT2 PT3 PT4 PT 
Figure 2-9: Thin-layer chromatogram of total CHCI, 3 extract of Iris tectorum Maxim. 
(PT) and its four sub-fractions (PTI - PT4) produced by preparative TLC. (It was 
developed in DS I mobile system. The left-hand side picture shows the developgd 
TLC plate observed under 254nm UV; the right-hand side picture shows the same 















Figure. 2-10: Percentage of remaining cells of COR-L23' after exposure to various 
concentrations of sub-fractions (PTI - PT4) for 48h (mean±SEM. n=2) 
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2.4.3 Isolation and purification of compounds 
After the cytotoxicity test for the sub-fractions (PTI - PT4), the component within 
PT2 band (Rf ==0.3 - 0.4 on TLC plate developed by mobile phase DSI) was 
recognized as the location for the active compounds on TLC plates. Meanwhile, a 
sub-fraction IT4 eluted by VLC in a large scale isolation (Figure 2-6 on page 63)) had 
almost identical mobility (Rf =0.3 38) in the same TLC system (Figure 2-11). Further 
cytotoxicity analysis of the VLC fractions ITI - IT6 also confirmed that IT4 was the 
most active sub-fraction (Figure 2-12) Therefore, the isolation and purification 
focused on IT4. 
------------------------------ 4- sok ent 
front 
-00. 
IT ITI IT2 IT3 IT4 IT5 IT6 IT 
. 4- baseline 
Fiff, ure 2-11: Analytical TLC plate of CHC13 extract (IT) and its VLC-fractions ITI - 
IT6 developed in mobile phase DS I 
As shown in Table 2-5, IT4 was the most active fraction for inhibition of cells 
proliferation, giving a lowest IGýO of 25ýtg/ml against lung cancer cells (COR-1-23). 
This value is significantly lower than the IGýo of 35ýtg/ml against lung normal cells 
(MRC-5) (p<0.05, Student's t-test). Practically, both IT3 and IT4 fractions exhibited 
selective cytotoxicity between COR-1-23) and MRC-5 cell lines. That means at a 
certain concentration of IT33 or IT4 the proliferation of COR-1-231 cells is inhibited 
more than that of MRC-5 cells. 
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Figure 2-12: Inhibition effect of sub-fractions ITI - IT6 on proliferation of CQR-L2-') 
cells (mean±SEM, n=2) 
F i 
IG50 (gg/ml) 
ract ons COR-L23 MRC-5 
ITI >50 >50 
IT2 >50 >50 
IT3 39±1.00 >50 
IT4 25±0.62* 335±1.55 
IT5 40±0.28 42±2.40 
IT6 >50 >50 
Table 2-5: The IG50values ([ýg/ml) of sub-fractions ITI - IT6 against COR-L23 (lung 
cancer) and MRC-5 (normal lung fibroblast) cells (IG50±SEM, n=2), * IG5OValue of 
IT4 against COR-L23 was significantly lower than that against MRC-5 (p<0.05). 
Crystallization of VLC fractions IT2 and IT-3 3A from MeOH yielded compounds IT2c 
and IT-33Ac (Figure 2-6 on page 633). They showed almost identical Rf values (0.56) on Zý t7l 
TLC as shown in Figure 2-133. However, IT2c did not quench UV(254nm), while the L- 
spot of IT3Ac was observed as a dark spot. This observation indicated that IT2c is a 
relatively saturated compound. 
After development in DS2 mobile phase system, IT33B and IT33C (sub-fractions of IT3) 
showed significant bands at Rt=0.37 which are in common with IT4. Thereby. they 
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were recombined with IT4 for further isolation. An extra experiment revealed that 
normal phase chromatography with silica gel 60 PF254 in an open column was not 
feasible for separation of fraction IT4. As previously described (section 2.13 on page 
50) a semi -preparative HPLC system was applied for separation and purification. 
That yielded four pure glassy compounds IT4C, IT4D, IT41H and IT417 (as shown in 
Figure 2-14). 





I% 4- baseline 
ITI IT2 1T3Ac IT3A IT3B IT3C IT3 IT4 IT2c IT3Ac 
FilZure 2-13: Analytical TLC plate of fractions: ITI - IT4, sub-fractions: IT' 3A - 
IT')C and compounds IT2c and IT3Ac. Left: ITM IT3C and IT4 have dark bands 
around Rf=0.37 on the same TLC plate developed in DS2 mobile phase; Right: TLC 
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2.5 Structural elucidation 
In the past two decades, many phytochernicals such as isoflavonoids. quinones and 
iridals have been discovered in the rhizomes of Iridaceous plants (Seki et al., 1994a: 
Ali et al., 1983; Minami et al., 1996). Iridal-type triterpenoids are biogeneticallý- 
interesting natural products because they were exclusively found in the rhizomes of 
Iridaceous plants (Marner et al., 1982; Seki et al., 1994; Abe et al., 1991). Some 
possible roles in living plant cells, such as antioxidant function (Marner and Kerp, 
1992) and drought-resistant activity (Bonfils et al., 1994) have been suggested for the 
iridals. This type of monocyclic and bicyclic triterpenoids have been recognized as 
characteristic metabolites of Iridaceous plants. In the present work, four pure 
compounds, which were isolated from the most active fraction IT4 by RP C- 18 HPLC 
system were eventually elucidated as iridal-type triterpenoids by several spectroscopic 
technologies. 
According to the literature a major group of compounds from Iris tectorum are 
triterpenoids with a saturated six-membered ring bonded to an U, P-unsaturated 
aldehyde function. Moreover, an aliphatic unsaturated hydrocarbon is present. These 
characteristics can be easily observed from the NMR results of those compounds 
isolated in the present work. 
Most iridal-type triterpenoids do not produce crystals, therefore, it is impossible to 
analyse their stereochernistry by X-ray crystallography. Nevertheless, some workers 
reported the determination of absolute configuration of some iridal-type triterpenoids 
by studying their 2-methoxy-2phenyl-2-(trifluoromethyl)acetic acid (MTPA) esters 
(Ohtani et al., 199 1) and CD spectra (Ito et al., 1999; Miyake et al., 1997). 
Basically, the complete assignment of proton and carbon, and hence structure 
elucidation of these four isolated triterpenoids were facilitated by the measurements of 
II -IC NMR, 1H NMR, HMQC, HMBC, 1H-1H COSY and NOESY spectra in the 
present study. The isolated triterpenes were numbered as in 57,60,61 and 65 for ease 
of interpretation of the data in Table 2-6 and Table 2-7. 
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2.5.1 Structural elucidation of compounds IT4E and IT4F 
IT4F was obtained as a yellowish glassy solid, and showed a major peak at 28.5 min 
on the HPLC chromatogram of active sub fraction IT4. This suggests that IT4F could 
be a major compound in 1. tectorum. Mass spectral investigation by ESI'. IvIS and 
CIMS gave peaks at m1z 497 [M+Na] + and m1z 492 [M+NH4] + (consistent with 
formula Of C30H5004Na and C3oH5004NH4,, indicating a molecular formula of 
C3oH5004 for IT4F). Such a formula is in keeping with the known occurrence of 
triterpenes such as isoiridogermanal (formula: C30H5004) previously found in Iris 
pallida (Krick et al., 1983). The 1H and 13 C NMR data of IT4F are superimposable 
with those of isoiridogermanal (57) in the literature (Krick et al., 1983, Seki et al.. 
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Isoiridogermanal (57) was first isolated from Iris pallida and Iris florentina in 1983 
(Krick et al., 1983) and subsequently from rhizomes of Belamcanda chinensis, Iris 
cristata Solander, Iris germanica, Iris japonica and bulbs and leaves of Tigridia 
pavonia (Bonfils and Sauvaire, 1996; Taillet et al., 1999, Takahashi et al., 2000: 
Effers et al., 1999), all Iridaceae. The absolute configuration has been NA-ell 
established as that shown in 57 by means of chemical and physical analysis (Ito et al.. 
1999). Furthermore, the absolute stereochernistry of the related compounds 7- 
irigermanal (58) and iriflorental (59) had previously been unequivocally established 
by X-ray crystal lo graphy (Mamer et al., 1982; Miyake et al.. 1997). On the basis of 
the above data, IT4F is identified as i so iridogerm. anal. 57. The possible biosynthetic 
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Chapter 2 Phytochemical investigation 
IT4E was obtained as a yellowish glassy solid. It showed a small peak at 27 min. 
adjacent to that of IT417 (57) on the HPLC chromatogram. Mass spectral investigation 
by EIMS gave a peak at m1z 474, suggesting it might have the same molecular 
formula (CNI-15004) as IT4F (57). Such a formula is also identical NA-ith that of 
iridobelarnal A, which was reported as a colourless viscous oil (according to 
observations in the present study, it is solid after being dried under N2 gas), an isomer 
of isoiridogermanal, with similar NMR signal values (Takahashi et al., 2000). In 
further investigation, the NMR data of IT4E were identical to those of iridobelamal A 






The most evident difference between IT4E and IT4F was observed in their NMR 
spectra, where the signals for the H-5 methine and one of the H-9 methylene 
hydrogens in the 1H NMR spectrum of IT4E were shifted to higher (A6H 0.52ppm) 
and lower field (A6H 0.67ppm), respectively, than the corresponding signals in the 
spectrum of IT4F (57) (see Table 2-7). Moreover, a remarkable difference was also 
observed in the chemical shifts of C-5 and C-9 in the 13 C NMR spectra of these 
isomers (Table 2-6). Thus, for IT4E. 6c(5) = 47.3ppm whereas for IT4F 6c(5) occurs 
at 43.4ppm and the corresponding C-9 signals are at 20.0 and 23.8ppm, respectively. 
Further evidence for the structure of the six-membered ring in these two molecules 
was also obtained from NOESY measurements (Figure 2-16 and Figure 2-17 on page 
79 - 80). The spectrum of compound IT4F (57) exhibited NOESY correlations 
between the aldehyde hydrogen signal H-1 OH 10.18) and that of H-5 (8H 3.3 1 ). and 
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between the signals of the C-3 vinyl methyl hydrogen OH 1.83) and one of the C-9 
methylene hydrogens OH 2.55). Meanwhile, in the spectrum of compound IT4E. the 
aldehyde hydrogen signal H- I OH 10.24) and the signal for the vinyl methyl (carbon 3) 
(6H 1.80) showed NOE correlations with one of the C-9 methylene hydrogen signals 
OH 3.22) and the H-5 OH 2.79), respectively. Those observations clearly indicated 
that IT4E is likely to be the geometrical isomer of IT4F (57) at the a, p-unsaturated 
aldehyde moiety (A 2(4)). IT4E is thus identified as iridobelarnal A, 60. 
As seen in Table 2-6, both sets of observed data of IT4F and IT4E superimposed well 
with those of isoiridogermanal (57) and iridobelarnal A (60), respectively. Moreover, 
the only difference between 57 and 60 is the stereochernistry of the vinyl CH3 and 
CHO: 57 is the Z isomer while 60 is the E. This evident difference was clearly 
observed between IT4F and IT4E. as shown in Figure 2-16 and Figure 2-17. 
Therefore, IT4F (57) and IT4E (60) were identified as isoiridogermanal (57) and 
iridobelarnal A (60), respectively. 
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Carbon No. ME Iridobelamal A Carbon IT4F 
--I 
isoiridogermanal 
I CHO 190.7 190.4 CHO 190.0 189.7 
2 C 133.1 132.7 C 133.2 132.7 
3 CH3 11.9 11.6 CH3 11.0 10.9 
4 C 163.5 163.1 C 162.8 162.8 
5 CH 47.3 47.0 CH 43.4 43.4 
6 C 45.2 44.9 C 44.7 44.7 
7 C 75.2 74.8 C 75.0 75.0 
8 CH2 38.0 37.7 CH2 37.0 37.0 
9 CH2 20.0 19.7 CH2 23.8 23.8 
10 CH2 36.9 36.6 CH2 36.9 36.9 
11 CH2 23.0 22.6 CH2 21.8 21.8 
12 CH 125.7 125.4 CH 125.3 125.0 
13 C 136.9 136.6 C 137.0 136.7 
14 CH 76.8 76.4 CH 76.7 76.7 
15 CH2 34.3 33.9 CH2 34.2 34.2 
16 CH 119.9 119.6 CH 119.9 119.6 
17 C 138.9 138.5 C 138.8 138.4 
18 CH2 39.8 39.5 CH2 39.8 39.8 
19 CH2 26.5 26.2 CH2 26.5 26.5 
20 CH 124.1 123.8 CH 124.1 123.8 
21 C 131.7 131.3 C 131.7 131.3 
22 CH3 25.7 25.4 CH3 25.7 25.7 
23 CH2 27.1 26.8 CH2 26.6 26.6 
24 CH2 32.0 31.7 CH2 32.7 32.7 
25 CH2 63.2 62.9 CH2 63.1 63.0 
26 CH3 17.8 17.5 CH3 18.0 17.9 
27 CH3 26.4 26.0 CH3 26.3 26.3 
28 CH3 11.9 11.6 CH3 11.9 11.9 
29 CH3 16.3 16.0 CH3 16.3 16.4 
30 CH3 17.7 17.4 CH3 17.7 17.7 
Table 2-6: CC NMR data (6, at 125MHz, in CDCI, ) of IT4E (60) 
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2.5.2 Structural elucidation of novel triterpenes IT4C and IT4D 
IT4C and IT4D were isolated as minor constituents along with IT4F (57) and IT4E 
(60) from 17g of the active sub-fraction IT4, which was obtained from the CHC13 
extract of Iris tectorum by the application of vacuum liquid chromatography (VLC) as 
shown in Figure 2-6 on page 63. IT4C and IT4D showed peaks with retention times 
of 20 min and 21.3 min,, respectively, on the HPLC chromatogram. (see Figure 2-14 on 
page 69). 
IT4C was isolated as a yellowish glass like solid, and exhibited a negative CD Cotton 
effect with maximum absorbance at 251.5nm and minimum absorbance at 338nrn 
(Figure 2-26 on page 98). Its UV spectrum (MeCN) showed k .. , (E): 252.5nm (12,623) 
and its [Od589nmwas +28.02' (CH2CI2, C= 9-1 X1 0-'g/Ml); Its ESIMS spectrum showed 
a molecular ion peak at m1z 513 [M+Na]+. The HRESIMS gave a peak at ai. `: 7 51 -3 ). 
' ) -5 
9 
(C30H5005Na requires 513.355). This indicated the molecular formulaOf C30H5005, 
with six degrees of unsaturation. The 13 C NMR and DEPT spectra revealed that IT4C 
has seven methyl, ten methylene, six methine and seven quaternary carbons. In 
addition, the 1H NMR signal at 10.15 (1 H, s) and 13 C NMR signals, 189.8,162.6 and 
133.3 ppm (see Table 2-8 and Table 2-9) suggest the presence of a fully substituted 
a, p-unsaturated aldehyde function. This was confirmed by observation of IR 
spectrum of IT4C, in which absorptions of the bands at 1708cm-1 and 1609cm-1 
suggested the a., P-unsaturated aldehyde stretch and conjugated C=C stretch., 
respectively. 
The above data suggested that IT4C has a structure very similar to that of IT4F (57), 
but has one more oxygen atom than this known triterpenoid. A clear indication of the 
structural difference between IT4F (57) and IT4C was provided by examination of the 
13 C NMR spectra. The 6c 61.6 (C-12) and 63.5 (C-13) indicated the likely presence 
of an epoxide function in IT4C. This was confirmed by the absence of signals for a 
double bond assigned to 12,13 in the 13C NMR spectrum of 57: 6C 125.3 (C-1-1) and 
137.0 (C-133) (Table 2-8). Moreover, IT4C differed from 57 by an upfield shift of the 
olefinic H-12 signal OH 5.25) in the 1H NMR spectrum of 57 to 6H 2.75 in that of 
IT4C, consistent NN-ith an epoxide hydrogen. Similarly the signal for the C-13) methý'l 
(H-28) NN-as shifted upfield from 6H 1.55 to 6H 1.20. These values stronoIN- suggested 
that the double bond at C-121 in IT4F ('57) was replaced bý- an epoxide function in 
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IT4C, giving a proposed structure for the latter as 61. 
OH 
28 14 16 
13 0 0 
12 29 
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A range of compounds with an analogous modification between an epoxide ring and 
double bond in natural products have been previously reported. For example, 
leucanthinin (62) and 3ot-hydroxyenhydrin (63) are melampolides isolated from aerial 
parts of Melampodium leucanthum (Quijano et al., 1997). Their IH NMR data differ 
from each other by an upfield shift of the olefinic H-5 from 6H 5.53 in the spectrum of 
leucanthinin (62) to 6H 3.18 in that of 3a-hydroxyenhydrin (63). Meanwhile, the 
signal for the C-4 methyl (H-15) was shifted from6H 1.97 in 62 tol. 72 in 63. These 
shifts of 1H NMR signals were simply due to the C-4 double bond in 62 was replaced 
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The shifts between these specific functions in the literature are very similar to those 
observed in the spectra of IT4F (57) and IT4C (61), and so give extra weight to the 
confidence in the proposed structure of IT4C (61). The structure elucidation of IT4C 
(61) was also supported by a review of a number of literature (Quijano et al., 1997., 
Lenis et al., 1998; Kubota et al.., 2003), which implied that the analogous epoxide 
function in different compounds exhibited similar signals in NMR spectra 
(summarized in Table 2-10). Except for the epoxide moiety signals, the spectral data 
of IT4C (61) closely resembled those of IT4F (57) (see Table 2-8). The complete 
structure of IT4C was drawn based on its I H-1H COSY (Figure 2-20), HMBC (Figure 
2-21), HMQC and NOESY measurements. Its proposed stereostructure with NOESY 
correlation signals is shown as Figure 2-22. IT4C therefore can be defined as (2z)-2- 
((2R, 3S, 4S)-4-hydroxy-3-(2-(3-((3E)-l-hydroxy-4,8-dimethylnona-3,7-dienyl)-3- 
methyloxiran-2-yl)ethyl)-2-(3-hydroxypropyl)-3,4-dimethylcyclohexylidene)- 
propanal, 61. 
IT41) was isolated as a yellowish glasslike solid and exhibited a negative Cotton 
effect with a maximum absorption at 253.5nm and minimum absorption at 3)7.5nm in 
its CD spectrum (Figure 2-26 on page 98). Its UV-spectrum (MeCN) showed 
252.5nm (13,358) and its [(X]589nm was -31.06' 
(CH2CI2., c=9.4x 10-3g/Ml) Its 
ESIMS spectrum showed a molecular ion peak at m1z 513 [M+Na]+ and the EIMS 
gave peak at m1z 491 [M+H]+. Its HRESIMS gave a peak of [M+Na]+ at m1z 51-),. -, ), 
59 
355), indicating the formula Of C30H , with six 
degrees (C30H5o05Na requires 51-3. ) 5005 
of unsaturation, identical with that of IT4C (61). 
The 13C NMR and DEPT spectra revealed that IT41) had seven methyls, ten 
methylenes. six methines and seven quaternary carbons. In its 13C NMR spectrum, 
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signals at 125.8(d), 135.6 (s), 124.3(d) and 131.8(s) revealed the likely presence of 
two isolated trisubstituted double bonds. Moreover, the following 1H and 1"C NMR 
signals: 6H 10.16 (1H, s), 6C 190.1 (d), 163.0 (s) and 133.2 (s) (Table 2-8 and Table 
2-9) along with IR vn,,,: 1713cm-1 (CHO) and 1608cm-1 (C=C) indicated the presence 
of a a, p-unsaturated aldehyde function, as that in IT4C (61). The relevant evidence 
for the structure of six-membered ring was obtained by comparison of its NMR data 
with those of IT4E (60) and IT4F (57). Moreover, both compounds IT4C (61) and 
IT41) exhibited NOESY correlation between the aldehyde hydrogen H-1 signal and 
that of H-5, also between the signals of the vinyl methyl H-3 and one H-9 in the 
NOESY spectrum (see Figure 2-25 on page 96). Therefore, IT4D and IT4C (61) have 
identical structure of the six-membered ring. So far they seem to be isomers. 
A possible structure for IT4D as an isomer of IT4C could be the analogous 16,17- 
epoxide, but this is discounted because the anticipated epoxide signals (at 6c 61.6 and 
63.5 in the spectrum of IT4Q were not present in the spectrum of IT413. There were, 
however, signals at 6c 77.1 (CH from DEPT) and 84.6 (quaternary from DEPT), 
which are more consistent with a cyclic hydroxyether structure as in 64. This could 
secondly be formed by attack by the 14-OH on a formal intermediate 16,17-epoxide, 
yielding 64, as shown as Figure 2-18 on page 86. 
OH 
64 
An estimation made by Cheml)raw'ý' Ultra 2004 (CambridgeSoft Corporation, USA) 
gave values for 6C of the tetrahydrofuran moiety as 77.3 (C-14), 39.6 (C-15). 77.9 (C- 
16), 87.4 (C-17), similarly. ACD/i-LaW' ACD/CNMR Predictor 8.0 (Advanced 
Chemistry Development Inc., Canada) calculated those 6c as 79.7 (C-14), 40.5 (C-15). 
77.7 (C- 16). 85.2 (C- 17), which are very near to those observed values: 80.1 (C- 14), 
39.4 (C-15), 77.1 (C-16), 84.6 (C-17). There is literature precedent for such 
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rearrangement: some naturally occurring compounds with a similar type of 
tetrahydrofuran moiety in their structure, had fairly similar '3C NMR signals for 
carbons 14 - 17: [6c 76.7 - 82.2 (C-14); 6c 337.9 - 40.0 (C-15), 6C 78.2 - 78.7 (C-16): 
6c 81.6 - 83.6 (C-17)] (Fan et al., 2001; Praud et al., 1995, Amico et al.. 1989: 
Kimura et al., 1997). As a result, 13 C NMR signals of C-14,15,16 and 17 in IT41) 
(65) are very similar to those in the spectrum of the literature (see Table 2-11) and 
strongly suggested the presence of a tetrahydrofuran moiety in IT41) (65). Moreover, 
this structure is likely to be biosynthesized from IT4F (57), as demonstrated in Figure 
2-18. The proposed structure 65 is supported by the observation of I H- IH COSY and 
HMBC (see Figure 2-23 and Figure 2-24 on page 95). Its proposed stereostructure 
with observed NOESY correlation signals is shown as Figure 2-25. Thereby, the 







The 13C and 1H NMR data of these isolated triterpenes are summarized in Table 2-8 
and Table 2-9. The IR, UV and CD spectra, and optical rotation behaviour of them 
showed a striking resemblance to one another (Figure 2-26 page 98 and Figure 2-27 
page 100). 
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Figure 2-19: Summary of structures of IT4C (61), IT4D (65). IT4E (60) and IT4F (57) 
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Carbon 
No. IT4C (61) IT4D (65) ME (60) IT4F (57) 
1 189.8 190.1 190.7 190.0 
2 133.3 133.2 133.1 1-3 
-3 3 11.0 11.0 11.9 11.0 
4 162.6 163.0 163.5 162.8 
5 43.6 43.4 47.3 43.4 
6 44.5 44.7 45.2 44.7 
7 74.9 75.1 75.2 75.0 
8 37.0 37.0 38.0 37.0 
9 23.8 23.9 20.0 2 33.8 
10 33.7 36.7 36.9 36.9 
11 22.6 21.9 23.0 21.8 
12 61.6 125.8 125.7 125.3 
13 63.5 135.6 136.9 137.0 
14 75.5 80.1 76.8 76.7 
15 31.8 39.4 34.3 34.2 
16 119.1 77.1 119.9 119.9 
17 138.8 84.6 138.9 138.8 
18 39.8 38.8 39.8 39.8 
19 26.5 22.7 26.5 26.5 
20 124.0 124.3 124.1 124.1 
21 131.7 131.8 131.7 131.7 
22 25.7 25.7 25.7 25.7 
23 26.6 26.6 27.1 26.6 
24 32.6 32.7 32.0 32.7 
25 63.0 63.0 63.2 63.1 
26 18.0 17.9 17.8 18.0 
27 26.3 26.33 26.4 26.3 
28 12.1 11.7 11.9 11.9 
29 16.2 20.0 16.3 16.3 
30 17.7 17.7 17.7 17.7 
Table 2-8: 13C NMR data of IT4C (61) - IT4F (57) (6, at 125MHz, in CDCI-, with 
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HO 
Figure 2-20: Observed correlations of the spin-spin coupled protons in 'H-lH COSY 
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nH 
HO 
Figure 2-23: Observed correlations of the spin-spin coupled protons in 'H-lH COSY 
spectrum of IT4D (65) 
3 
HO 
FilZure 2-24: Observed HMBC (long-range 'H-1"C COSY spectra) correlations of 
IT4D (65) 
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18 H OH 
vie 22 
FiRure 2-2-5: Observed NOESY 'H-'H correlation signals and proposed 
stereostructure of IT4D (65) (Some hvdrogen atoms omitted for clarity). 
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Compounds IT4C (61), IT4D (65) and IT4F (57) were prepared in acetonitrile 
solution. Dilutions were then made to obtain an optimal concentration for CD 
determination. The spectra were acquired on a Jasco J720 specti-polarimeter at 0.4 
mg/ml. A rectangular cell with I mm. path length was employed in the region of 420- 
180nm wavelength. The following parameters were used: 2nm bandwidth, 4s time 
constant, 20nm/min speed and 0.5nm step size. All spectra were solvent baseline 
subtracted. 
The CD spectra for iridals IT4C (61) and IT41) (65) are similar to that of IT4F (57). 
They all had negative Cotton effect with a maximum absorption around 253.5nin and 
minimum (multiple) absorption around 337.5= (as shown in Table 2-12 and Figure 
2-26), which are typically associated with7r-7r* (conjugated carbonyl group) and n-7[* 
(carbonyl group) transitions in an asymmetric environment, respectively. This 
observation coincides with those of isoiridogermanal in the literature (Takahashi et al., 
2000; Miyake et al., 1997). In addition, the NOE correlation signals of the six- 
membered ring observed in 2D NMR spectra of IT4C (61) and IT41) (65) are highly 
coincident with those of isoiridogermanal in the literature (Seki et al., 1994b). 
The monocyclic iridal (57) and iridals having an epoxy-function such as (61) or 
tetrahydrofuran moiety (65) have only an a, p-unsaturated aldehyde function as the 
conjugated system (chromophore). Therefore, it is difficult to determine their 
absolute configuration directly from those CD spectra. The configuration of 
isoiridogermanal has been thoroughly elucidated (Seki et al., 1994b; Ito et al., 1999) 
by means of the modified Mosher's method using methoxy- 
(trifluoromethyl)phenylacetic acid (MTPA) esters as described and applied in 
previous research (Ohtani et al., 1991). However, the absolute configuration of IT4C 
(61) and IT41) (65) at C-14 were not examined in the present research due to the 
limited amount of pure sample. 
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Fi2ure 2-26: The UV/CD spectra of IT4C (61). IT4D (65) and IT4F (57) 
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Com d UV s ectra CD spectra poun s krnax Amax kmax mdeg 
IT4F (57) 335. Onm -1.29 
252nm 0.85 253.5nm +5.49 
IT4C (61) - 338. Onm -1.60 
252.5m-n 1.03 251.5nm +11.72 
IT4D (65) 337.5nm -1.1 252.5nm 1.09 253.5nm +5.35 
Table 2-12: The CD spectral data of compounds IT4C (61), IT4D (65) and FF4F (57) 
The structural proposals were also supported by analysis of the IR spectra (see table 
Table 2-13 and Figure 2-27). 
Assignment Wavenumber (cm-1) 
IT4C IT4D IT4F 
Hydroxyl 3394 3402 3399 
Aliphatic C-H stretch 2967 2968 2965 
2931 2928 2933 
2875 2863 2876 
CHO (a, p-unsaturated aldehyde) 1708 1713 1710 
C=C unconjugated 1655 1650 1651 
C=C conjugated 1609 1608 1609 
O-H bending of C-OH group 1515 
1448 1449 1447 
1375 1375 1375 
1314 1313 1314 
1290 1289 1289 
1205 1203 1204 
C-OH stretching of C-OH group 1182 1180 
1090 1090 
1050 1054 1050 
1016 
Alkene C-H bending 907 908 906 
* Absorbance at 863) in IT4C was likely 863 879 
due to epoxy group; absorbance at 734 in 812 812 
IT41) caused by the solvent residue 742 734 741 
(CHC12)- 701 
Table 2-13: Summary of assignments and peaks of the infrared spectra of IT4C (61). 
IT4D (65) and IT4F (57) (The assignment was based on the characteristic group 
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The optical rotation of IT4C (61), IT4D (65) and IT4F (57) were measured on a 
Perkin-Elmer 141 polarimeter at the sodium D line (ý, =589nm) and Hg line 
(k=578nm). Experiments were carried out at room temperature (23'C). Instrument 
calibration was completed with sucrose (obtained from BDH) at 14.59mg/ml in 
distilled water (see Table 2-14) as reference standard. 
Laser light path volume OR degree [cc] 
Sodium D line I Ocm 6ml +64.430 
Q, =589nm) I Ocm Iml +65.110 
Hg line I Ocm 6ml +67.170 
(k=578=) I Ocm Iml +67.580 
Table 2-14: Instrumental calibration of optical rotation using sucrose 
Solutions of samples were prepared by dissolving in 1.5ml CH2CI2. Optical rotation 
(sodium D line, X=589nm and Hg line k=578nm) obtained on the polarimeter by 
using aI Ocm light path cylindrical cell (volume =I ml) are shown in Table 2-15. The 
optical rotation of IT4F (57) at 578mn([(X]578nrn =+39.751) is very similar to that of 
isoiridogermanal (57) ([OC]578nm +46.7', CH202, c=7.6) in the literature (Krick et al., 
1983). 
Comp. Conc. (X, 0-3g/Ml) IOC]589nm IOC]578nm 
IT4F 8.9 +35.27' +39.75' 
IT4C 9.1 +28.020 
IT4D 9.4 -31.06' 




2.5.3 Identification of 7-0-methyl aromadendrin 
Compound IT2c and lT3Ac were isolated and crystallized from sub-fractions IT2 and 
IT3A respectively. They were identified as known flavonoids by comparison of their 
instrumental analysis data (NMR, EIMS and IR) with those in the literature. 
IT2c was identified as 7-0-methyl aromadendrin (66), because the instrumental 
analysis data are very similar to those in the literature (Abdel-Sattar et al.. 2000: 
Balza and Towers,. 1984; Hanawa et al., 1991) (as shown in Table 2-16 and Table 
2-17). The positive Cotton effects with a maximum absorbance at ')')Onm and a 
minimum absorbance at 292m-n in the CD spectra of IT2c indicates the configuration 
at C-2 to be R in this dihydroflavonol structure (Ingham et al., 1986). Since the trans 
orientation of H-2 and H-3 in IT2c was apparent from 1H NMR coupling constants 
(both are J=11.61-1z), the R configuration at C-3 can be determined. These 






In a latest paper on 7-0-methyl aromadendrin (66) (Abdel-Sattar et al., 2000), NMR 
spectra were measured in CD30D at 50OMHz (70MA-a), however, in an early paper 
(Balza and Towers, 1984), the NMR spectra were measured in CDC13 at 8OMHz 
(70MA-b) (shown in Table 2-16). The differences of the chemical shift values 
between IT2c and published data may due to the different deuterated solvents used in 
the NMR experiments. The assignment of the carbon signals in Table 2-16 is based 
on the HMBC results (shown in Figure 2-28). 
It is x'ery clear that, not only the NMR data, but also the EIMS fragments signals of 
IT2c matched those of 7-0-methyl aromadendrin (66) in the literature well (see Table 
102 
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2-18). Moreover, the data of CD spectra of IT2c (Table 2-19 and Figure 2-29) are 
highly consistent with those in literature (Herz et al., 1972). Thus, IT2c was 
identified as 7-0-methyl aromadendrin (66). 
lH NMR IT2c a b 
2-H 5.12 d 5.03 d 5.05 d 
(J=l 1.6Hz) (J=1 1.5Hz) (J= I 2Hz) 
3-H 4.69 dd 4.56 d 4.5 5 dd 
(J= 11.6,4.2Hz) (J=1 1.5Hz) (J= 12,1.5 Hz) 
3-OH 4.79 d ? 3.47 d 
(J=4.2Hz) (J=1.5Hz) 
5-OH 11.69s ? 11.18S 
6-H 6.09 d 6.03 d 6.05 d 
(J=2.2Hz) (J=2.2Hz) (J=2.5Hz) 
7-OCH3 3.86s 3.81 s 3.83s 
8-H 6.05 d 6.08 d 6.15 d 
(J=2.2Hz) (J=2.2Hz) (J=2.5Hz) 
2'-Hý 6-H 7.43 d 7.37 d 7.45 d 
(J=6.8Hz) (J=8.8Hz) (J=8.5Hz) 
3'-H, 5'-H 6.90 d 6.87 d 6.90 d 
(J=8.6Hz) (J=8.8Hz) (J=8.5Hz) 
4'-OH 8.62s ? 4.90s 
Table 2-16: Comparison of lH NMR spectral data of IT2c (6, at 125MHz, in acetone- 
Owith those of 7-0-methyl aromadendrin (66) in the literature (a: Abdel-Sattar et al, 
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Figure 2-28: Observed HMBC correlations of IT2c 
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13 C NM R IT2c a 
2 CH 84.5 85.1 
3 CH 73.2 73.9 
4 c 198.7 198.6 
5 c 164.7 164.9 
6 CH 95.8 96.5 
7 c 169.3 169.7 
7-OCH3 CH3 56.4 56.9 
8 CH 94.7 95.5 
9 c 164.0 164.2 
10 c 102.1 102.8 
1, c 129.0 129.0 
2% 6' CH 130.3 130.4 
Y, 5' CH 115.9 116.6 
4' c 158.9 159.1 
Table 2-17: Comparison of the 13 C NMR spectral data (6, at 125MHz, in acetone- 
-1 of IT2c with those of 7-0-methyl aromadendrin (66) in the literature (a: Abdel-Sattar 
et al., 2000) 
IT2c a b c 
302 [M]+ (50) 302 [M]+ (100) 302 [M]+ (30) 302 [M]+ (17) 
273 (58) 273(100) 273 (50) 273 (38) 
179(17) 179(50) 179(35) 179(15) 
167(100) 167(100) 167(100) 167(100) 
136(19) 136(22) 
134(36) 134(100) 134(70) 134(37) 
107(20) 107(65) 107(75) 107(26) 
Table 2-18: Comparison of the EIMS m1z (rel. int. ) result of IT2c with those of 7-0- 
methyl aromadendrin (66) in the literature (a: Abdel-Sattar et al., 2000; b: Balza and 
Towers, 1984; c: Hanawa et al., 1991) 
UV spectra CD spectra 
kmax Amax kmax mdeg 
33 Omn +2.71 
289.5nm 0.64 292nm -9.83 
255run +3.00 
218mn no 0.77 
1 
218nm +17.17 
Table 2-19: The CD spectra results of IT2c (66) 
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FiRure 2-29: UV/CD spectra of IT2c (66) 
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2.5.4 Identification of tectorigenin 
lT3Ac was identified as tectorigenin (24), because the spectroscopic data (Table 2-20, 
2-21 and 2-22) were consistent with those in the literature (Horie et al.. 1998: Bae et 
al., 1999; Qin et al., 2005; Hanawa et al., 1991 a). The published data differ slightly 
from each other but nevertheless the data of IT3Ac are similar enough to allow 
unequivocal identification. Both 1H and 13 C NMR data (Table 2-20 and Table 2-21) 
are significantly distinguishable with those of hispidulin (67), an isomer has similar 
structure and identical EIMS fragments as that of 24. 
OH 
HO 78902 HO 
63 




The NMR spectra data of hispidulin in the literature (Nakasugi and Kornai, 1998) 
were also listed for discrimination. The 1H NMR data of lT3Ac were identical with 
those of tectorigenin (24) in the different sources. At the same time they were 
significantly distinguishable from hispidulin (67) at 3-H of the latter (see Table 2-20). 
The 13 C NMR data of tectorigenin (24) and hispidulin were also significantly 
distinguishable at C-2 and C-3 (see Table 2-21). 
The differences of chemical shifts in 13C NMR data among the three references may 
be due to the incorrect assignments of three quaternary carbons: C-5. C-7 and C-9 in 
the publications. The assignments of NMR signals for the structure of tectorigenin 
(24) in the present study is consistent with those reported by Horie et al. (1998). 
Except for the difference in relative assignments of those three quaternary carbons, 
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1H NMR IT3A tectorigenin c 
a b c 
hispidulin 
2-H 8.34s 8.33s 8.29s 8.33 s 3-H 6.76s 
5-OH 13.06s 13.07s ? 13.06s 5-OH 1-3'. 06 s 
6-OCH3 3.75s 3.76s 3.88s 3.75s 6-OCH3 
-3.74s 7-OH 10.78s 10.78s ? 10.76s 7-OH ? 
8-H 6.50s 6.51 s 6.49s 6.50s 8-H 6.5 7 
2'-Hý 6-H 7.38 d 7.38 d 7.38 d 7.37 d 2'-H, 6*-H 7.91 d 
(J=8.6Hz) (J=8.3Hz) (J=8. lHz) (J=9.5Hz) 
3'-Hý 5'-H 6.82 d 6.83 d 6.82 d 6.82 d 3"-H, 5'-H 6.91 d 
(J=8.6Hz) (J=8.3Hz) (J=8. lHz) (J=9.5Hz) 
4'-OH 9.60s 9.61s ? 9.59s 4'-OH 
Table 2-20: Comparison of lH NMR spectral data (6, at 50OMHz, in DMSO- )o 
IT3Ac (24) with those of tectorigenin and hispidulin (67) in the literature (a: Horle et 
al., 1998; b: Bae et al., 1999; c: Qin et al., 2005; Nakasugi and Komai, 1998) 
13 C NMR IT3A tectorigenin c 
a b c 
hispidulin 
2 CH 154.0 154.0 153.9 153.6 C 163.7 
3 c 121.7 121.7 123.8 122.1 CH 102.3 
4 c 180.5 180.5 180.5 181.4 C 182.0 
5 c 153.2 153.2 152.7 158.2 C 152.7 
6 c 131.3 131.3 131.4 132.1 C 131.4 
6-OCH3 C 59.8 59.9 59.0 60.8 c 59.9 
7 c 157.3 157.3 153.2 154.8 C 157.8 
8 CH 93.8 93.8 93.8 94.7 CH 94.3 
9 c 152.6 152.7 157.5 153.9 C 152.5 
10 c 104.7 104.8 104.8 105.6 C 103.8 
11) c 121.1 121.1 121.0 122.6 C 121.2 
2', 6' CH 130.1 130.1 130.1 131.0 CH 128.4 
3', 5' CH 115.0 115.0 115.0 116.0 CH 115.9 
4' c 157.4 157.4 157.4 157.9 C 161.2 
Table 2-21: Comparison of 13 C NMR data (6, at 125MHz, in DMSO- ) of IT3Ac (24) 
with those of tectorigenin and hispidulin (67) in the literature (a: Horie et al.. 1998, b: 
Bae et al., 1999; c: Qin et al., 2005; Nakasugi and Komai, 1998) 
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IT3Ac c d 
3 00 [M]+ (100) 3 00 [M]+ (100) ")Oo [M]+ (100) 
285 [M-Me]+ (54) 285 [M-Me]+ (65) 285 [M-Me]+ (52) 
282 [M-H201+ (38) 282 [M-H201+ (47) 282 [M-H-, O]+ (38) 
271(6) 271(8) 
257(49) 257 257(65) 
149(9) 
139(8) 139(13) 
118(7) 118(22) 118(11) 
Table 2-22: Comparison of the EIMS m1z (rel. int. ) result of IT3Ac (24) with those of 
tectorigenin in the literature (c: Qin et al., 2005; d: Hanawa et al., 199 1 a) 
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CHAPTER 3 
ACTIVITY OF ISOLATED COMPOUNDS 
3.1 Cytotoxicity 
Six isolated compounds: isoiridogermanal (57), iridobelamal A (60), IT4C (61). IT41) 
(65), 7-0-methyl aromadendrin (66) and tectorigenin (24) together with two 
flavonoids, luteolin (22) and genistein (51) (as positive controls), were tested for 
cytotoxicity using the SRB assay. All of them showed dose-dependent inhibition of 
proliferation in the six cell lines tested for 48h. Their cytotoxicities were evaluated by 
calculation of the IG50 (the concentration that inhibits cell growth by 50%). 
As shown in Figure 3-1 and Table 3-1, tectorigenin (24) is the least cytotoxic 
compound with the highest IG50 among the four flavonoids. Its lGio values against all 
tested cell lines are higher than 100ýtkl (as high as 207.2[iM and 234.5ýM against 
C32 and HBE14o-). Obviously, luteolin (22) is the most cytotoxic one with IGýo of 
II ýM and 9.4ýM against COR-1-23 and HepG2, respectively. Generally, the order of 
cytotoxicly for these four flavonolds is luteolin (22) > 7-0-methyl aromadendrin (66) 
> genistein (51) > tectorigenin (24). This result also reveals that MCF-7 seems to be 

















Fi, c, Fure 3-1: The IG.; o values ([ýM) of g(genistein (51). tectorigenin 
(24). 7-0-methyl 
aromadendrin (66) and luteolin (22) against six cell linesjLG5()±SEMý nfýj 
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Cell lines 51 24 
_ 
66 22 1 
COR-L23 62.7±8.98 18 9.3' ± 6.5 5 -32.8 ± 
0.5 0 11.0±0.67 : 
MRC-5 40.6±2.50 134.8±4.76 2 -3. _3 ± 
0.5 5 1 
-3.22 ± 1.17 MCF-7 42.6±0.48 105.0±1.98 2 1.0 ± 1. -37 
17.9±1.11 
HepG2 51.8 ±4.02 148.8±2.48 24.5 ±1.7-3 9.4±1.22 
C32 68.0±2.17 207.2 ± 1-3.7 -3 
332.8 ± ). 2 5 25.2 ±0.91 
HEB I 4o- 52.0±1-91 234.5±14.14 40.4±0.74 25.9±0.24 
Table 3-1: The IG50values (IýM) of genistein (51), tectorigenin (24), 7-0-methvl 
aromadendrin (66) and luteolin (22) against six cell lines OGýo±SEM, n=3) 
By comparison, the iridal-type triterpenes have the same level of cytotoxicity (shown 
as Figure 3-2 and Table 3-2) as those of the active flavonoids (genistein [51], 7-0- L- 
methyl aromadendrin [66] and luteolin [22]). IT4C (61) is the least cytotoxic 
compound among those four iridal-type triterpenes tested. It has IGýO of 34.81, M and 
40.4ýM against COR-L23 and C-32, respectively. The other three triterpenes: IT4D 
(65), IT4E (60) and IT4F (57) showed similar cytotoxicity with lGio around II ýM 
and 23ýM against MCF-7 and C32 respectively. IT41) (65) and IT4F (57) have very 
similar IG50 against all tested cell lines. IT4E has the lowest IG5o of 5.7ýtM against 















Fieure 3-2: The IG5o values (ýM) of IT4C (61). IT4D (65), IT4E (60) and IT4F (57) 
against six cell lines (IGio±SEM. n=3) 
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Cell lines 61 65 60 
- 
57 
COR-L23 34.8±0.86 19.0±0.44 13.9±0.27 15.7±1.84 
MRC-5 26.9±4.39 21.6±0.67 13.0±0.83 20.4±0.80 
MCF-7 17.6±0.51 10.6±1.42 10.7±1.22 11.0±2.11 
HepG2 28.5 ±2.07 20.4±0.61 17.9±0.32 22.0±2.00 
C32 40.4±2.29 24.6±2.02 22.6±0.97 23.5 ±0.80 
HEB I 4o- 17.4±0.58 13.5 ±0.59 5.7±0-23 13.2±0.71 
Table 3-2: The IG50values (11M) of IT4C (61), IT4D (65), IT4E (60) and IT4F (57) 
against six cell lines (IG50±SEM, n=3) 
3.2 Methods used to investigate apoptotic activity 
The integrity of the cytoplasmic membrane is essential to cell function. Although at 
least some cells can survive transient small breaches of the membrane, longer-term or 
larger defects may deprive the cell of materials it would normally accumulate, and 
may also expose it to toxins it would normally exclude. Thus, cells with a 
demonstrable loss of membrane integrity are dead (Shapiro, 2003). The selected 
methods for apoptotic investigation are dual staining systems, which are based on the 
changes in membrane permeability that occur during apoptosis. 
3.2.1 Flow cytometry 
The observation of cellular phenomena has relied primarily on microscopic analysis. 
The microscope has long been the symbol of the biologist for much of the last century 
and before. However, microscopic studies carry an inherent limitation for analyzing 
individual cells. That is the limited number of cells that are observable in such studies 
precludes the quantitative (cell-by-cell) analysis of entire populations (Ranalli et al., 
2003). Flow cytometry overcomes this limitation by allowing the analysis of a large 
number of cells in a very short time, greatly simplifying the quantitative. real-time 
observation of phenomena such as apoptosis in a large population. Therefore, flow 
cytometry has been applied to the study of apoptosis in a variety of ways. 
Apoptosis was originally identified morphologically. The explosion of studies on 
apoptosis in recent years has clarified that it represents the mode of death that is 
actively driven by the cell. a complex process that is also described as programmed 
cell death. Conversely. necrosis represents a passive consequence of gross injury to 
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the cell. It is morphologically different from apoptosis, and its physiological 
consequences are also very different from those of apoptosis (Searle et al., 1982: Buja 
et al., 1993) (see Table 1-2 on page 24). Since apoptosis is a very common 
phenomenon during embryogenesis as well as adult life, and a frequent response of 
cells to drugs in the course of therapy, its quantitative evaluation represents an issue of 
considerable relevance. Flow cytometry is the technique of choice for the quantitation 
of apoptosis. A multitude of methods have been developed to identify apoptotic cells 
by flow cytometric analysis each of them differently suitable to different experimental 
conditions (Darzynkiewicz et al., 1992). 
The integrity of the plasma membrane of cells underging apoptosis is preserved and 
most functions of the membrane remain unchanged (Darzynkiewicz et al., 1997). 
Apoptotic cells, thus, exclude "viability assay" dyes such as trypan blue or Pl. This is 
in contrast to necrotic cells., where one of the earliest changes is loss of membrane 
function and its structural integrity; accordingly they can uptake trypan blue or PI 
readily. By the ability to uptake propidium iodide (PI), necrotic cells can be clearly 
distinguished. On the other hand, apoptotic cells can be erroneously classified by 
flow cytometry as viable cells (Lennon et al., 1991). By using this sort of dye in 
combination with other markers, such as fluorescein-diacetate (FDA) or Hoechst 
33258, apoptotic and healthy cells can be readily distinguished (Sasaki et al., 1987; 
Ormerod et al. , 1993; 
Schmid et al.,, 1994). 
An unequivocal method to distinguish apoptotic from necrotic cells by flow 
cytometry does not exist. Rather, it is necessary to discriminate necrotic cells from 
apoptotic cells using different flow cytometric methodologies available to measure 
apoptosis. The recently developed reagents and technologies are generally based on 
the following distinctive features of apoptosis (Ranalli et al., 2003): 
" DNA fragmentation 
" Plasma membrane alterations 
Mitochondrial changes 
Activation of caspases. 
The plasma membrane alteration assay with annexin-V FITC and the cell N, iabilltxr 
assay with fluorescein diacetate (FDA) and propidium iodide (PI) staining have been 
adopted in this project for the detection of apoptosis. The cell cycle analysis assay 
il? 
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using PI was applied to give more detailed evidence for the features of apoptosis 
induced by the compounds in question. The selection was based on their features. 
such as high sensitivity, specificity and low cost. The physical properties of applied 
agents used are listed in Table 3-3. 
Agent Excitation Emission 
FITC 488nm 525mn 
FDA 485nm 538mn 
Pi 536nm 620nm 
Table 3-3: Optical -Properties of fluorescent probes used 
3.2.2 Main features of flow cytometer 
Generally, the flow cytometer is an instrument that accepts an input of liquid- 
suspended cells, passes them one by one through a light source, and measures a 
variety of light scattering and fluorescence properties for each cell. Input cells are 
passed through a capillary at a rate of thousands per second, and individually 
subjected to light,, normally in the form of a focused laser beam or equivalent 
monochromatic light source. When the fluorescent probes are applied, fluorescence 
characteristics of each cell are collected by light sensors, and these data can 
subsequently be analysed by various software packages (Ranalli et al., 2003). The 
instrument employed for the apoptosis assay in this project is a bench top FACScan x 
(BD Biosciences, San Jose, CA) flow cytometer. The histograms and dot plots 
presented in the results were made with Cell Ques? ', which is a FCM application base 
on G4 Power Macintosh. Five parameters involved in cell cycle analysis and 
apoptosis assay are: 
Forward light scatter (FSC) 
Side light scatter (SSC) 
* Fluorescence channel FL I 
e Fluorescence channel FL) 
0 Fluorescence channel FL-3 3. 
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The pulse height, area and width of each fluorescence parameter are measured at the 
same time as data acquisition for the tested sample. The parameter settings for the 
assays used are listed in Table 3-4. Forward scatter is a measure of cell size, while 
side scatter is a measure of cell granularity (complexity). The shrinkage and blebbing 
characteristic of apoptosis reduces cell size and increases cell surface complexity, 
resulting in a population on the dot plot with distinct light scattering properties 
(Ormerod et al., 1995). Nevertheless, the morphological assessment of apoptosis 
based on a scatter plot of FSC vs SSC is often difficult to distinguish clearly bet"N-een 
the apoptotic and healthy populations, as they frequently partially overlap. 
Furthermore, characteristic morphological changes are hidden upon detachment in 
some adherent cell lines. In practice, this technique is most useful for distinguishing 
apoptotic from healthy cells in thymocytes, freshly isolated peripheral blood cells, and 
some lymphoid cell lines. It is advisable to avoid this type of analysis in adherent 
cells lines (Mentz et al., 1998). This method was therefore not employed in present 
project due to its poor reliability. 
Emission ranges DNA FDA/Pl Ann/Pl 
for detectors fragmentation staining staining 
FLI 530±15 mu FDA FITC 
FL2 585±21 mn Pi 
FL3 675±25 nm Pi Pi 
Table 3-4: Fluorescent signals (emission wavelength) detected by FCM in each assays 
3.2.3 Protocols for apoptosis assay with flow cytometer 
3.2.3.1 Determination of the cell cycle by DNA analysis 
Propidium iodide (PI) (68) (Sigma-Aldrich, P4170) is the most widely-used 
fluorescent dye for staining DNA in whole cells (or isolated nuclei). PI (68) does not 
cross the intact plasma membrane of viable cells. However, PI (68) can readily enter 
dead cells or cells in late stages of apoptosis that have damaged plasma membranes. 
In cell cycle analysis assay, PI (68) intercalates into the DNA helix of fixed or 
permeabilized cells. Because PI (68) can stain both double-stranded RNA (dsRNA) 
and DNA (dsDNA). cells must be treated with RNase to ensure that PI (68) staining is 
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DNA specific (Krishan, 1975). 
In a histogram of DNA analysis (as seen in Figure 3-3)). cells in Gi or Go will contain 
a single copy of the genome (see Figure 3-4), and will appear as a sharp peak, while 
cells in G2 or M phase will have a double content of DNA and will appear as a second 
peak with approximately double intensity in the red channel. Cells in S phase will 
have variable DNA content and will be distributed in the area between the two peaks. 
The proportion of cells in each cell cycle phase can thus be determined by calculating 
the area of the different peaks (Wieder, 1999). Apoptotic cells will have relatively 
low red fluorescence intensity, due to their decreased DNA content, and will appear as 
a sub-G, peak (Darzynkiewicz et al., 1992) (see Figure 3-3). 
NH 
Me 




It has been recognized independently in several laboratories that apoptotic cells have 
reduced DNA stainability following staining with a variety of fluorochromes, such as 
PI and Hoechst dyes because of the degradation of DNA and its subsequent leakage 
from the cell (Ojeda et al., 1990; Afanasev et al., 1986). These account for the 
appearance of cells with low DNA stainability (lower than that of cells in G, phase) 
due to their hypodiploid DNA content. When the cultures are treated with various 
drugs, the sub-Gi peak can be considered as the marker of cell death by apoptosis 
(Darzynkiewicz et al., 1992). However, this method has been replaced by some 
recently developed approaches. such as annexin V staining to detect changes in 
membrane lipid distribution. which is capable of detecting apoptosis in an earlier 
stage than assays based on nuclear changes. 
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Filzure 3-3: DNA content histogram f COR-L23 cells after exposure to 20LIM 
genistein for 48h (Keys: MI= sub-G I peak; M2= GO/G I peak; M3= S peak; M4= 
G? /M peak) 
Division of cell 
4. 








Figure 3-4: Illustration of the variation of DNA content during cell cycle (modified 
from http: //Ieaminglab-co. uk/headstart/imacyes/cycle I ajpgý 
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3.2.3.2 Protocol of cell cycle analysis with PI 
1. Cells were cultured in 6-well plates under a humidified 5% C02 atmosphere at 
37'C. The seeding density was I million cells per well. 
2. Plates were preincubated for 24h before the solutions of drugs or control were 
added to each well. After a period of exposure (48h), cells were harvested by 
trypsinization with trypsin/EDTA solution (Sigma-Aldrich, T4049), and 
centrifuged at 1,500 rpm. 
3. Cells were fixed with ice-cold 70% ethanol (> I hour, 4'C) ensuring that the 
cell suspension was thoroughly resuspended. Ethanol was added dropwise 
while vortexing the cells to ensure fixation of all cells and to minimize 
clumping. Once fixed, cells may be stored for months in 70% ethanol at 4'C 
prior to PI staining and flow cytometric analysis. 
4. Cell pellets (I x 106) were made in tubes (at 1,500rpm, 5 min) and washed once 
in PBS. Ethanol-fixed cells required higher centrifugal speed (2,000rpm) to 
be pelleted tightly since they become more buoyant upon fixation than freshly- 
isolated or cultured cells. Care was be taken when aspirating off supernatants 
after centrifugation steps (especially after spinning cells out of ethanol) so that 
the cell pellet was not disturbed and no cells were lost. 
5. Cells were incubated with 100 ýtl of lmg/ml ribonuclease A (RNase A) 
(Sigma-Aldrich, R5500; 100 Kunitz units/mg protein) for 30 min at 37'C. 
The RNase A was dissolved in PBS at a concentration of lmg/ml, aliquoted, 
and stored frozen (-80'C). 
6. Cells were stained with 5ýtg/ml PI (Sigma-Aldrich, P4170; Stock PI is I mg/ml 
in PBS) solution in staining buffer. Stained cells were incubated at room 
temperature for 30 min before detection by FCM. Samples were stored at 4'C 
and protected against light until flow cytometric analysis (within 24 hours). 
7. Samples were analysed by flow cytometry using linear amplification. The 
flow rate was maintained at less than 400 events per second. 20,000 events 
were acquired for each scan. A one-dimensional plot of the red channel (FL2) 
, o, -as engaged. 
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3.2.3.3 Result of positive control (vinblastine sulphate) 
Vinblastine sulphate (69) (Sigma-Aldrich, V1377) was tested as a positive control to 
optimize the protocol of cell cycle analysis. As shown in Figure 3-5, cells cultured 
under normal conditions (control) showed the highest peak in the region of Go/Gi 
phase and a small low peak in G2/Mphase. Following vinblastine treatment, the 
G2/M peak dramatically increased from 15.7% (in the control) to 71.3% after 
exposure to 45nM vinblastine sulphate (69), and the peaks of GO/Gj and S phases 
decreased from 61.3% to 5.8%, and 13.8% to 3.7%, respectively (see Figure 3-6). 
The significant accumulation of cells (statistical results available in Table 3-6 on page 
144) clearly indicates that vinblastine sulphate (69) efficiently arrested the cell cycle 
progress in COR-L23 cells at the G2/Mphase (as shown in Figure 3-5). This result is 
consistent with those in the literature (Aoyama et al., 1998) and testifies that the 
established cell cycle analysis protocol with COR-L23 cell line was working properly 
in the present work. Therefore, the results of the subsequent tests on the previously 
untested compounds may be considered reliable. 
















Figure 3-5: Overlay histogram of cell cycle analysis for CQR-L2') treated by various 


















Figure 3-6: Effect of vinblastine sulphate (69) On cell cycle of COR-L23 cells after 
48h exposure 
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3.2.3.4 Fluorescein diacetate (FDA) 
Fluorescein diacetate (FDA) (70) (Fluka, 31545) is an electrically neutral, non- 
fluorescent molecule. It can penetrate the cell membrane and can be hydrolyzed to 
fluorecein by non-specific esterases in viable cells. The metabolite, fluorescein, is 
highly fluorescent and charged, so therefore, can accumulate in and be retained in the 
cytoplasm of intact cells for short periods of time, causing the living cells to become 
fluorescent (green) (Skehan, 1999). In the case of apoptotic and dead cells. 
fluorescence is not produced due to the lack of esterases or the FDA leaking out of the 
cells because of poor membrane integrity. In addition, an apoptotic cell is unable to 
metabolize FDA (Ormerod et al., 1993; Tolleson et al., 1996). PI, a nucleic acid 
binding-dye (red fluorescence), cannot penetrate the membrane of viable cells, but can 
enter cells readily during the cell death process due to a loss of membrane integrity. 
Therefore,, FDA and PI co-labeling is able to distinguish viable cells (FDA positive, PI 
negative) (FDA+/PI_) and dead cells (FDA-/PI+) from apoptotic cells (FDA-/Pl-) 
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3.2.3.5 Protocol of FDA/PI staining 
1. Cells were cultured in 6-well plates under a humidified 5% CO, atmosphere at 
37'C. The seeding density was I million cells per well. 
2. Plates were preincubated for 24h then the solutions of drugs or control were 
added to each well. After a period of treatment, cells were harvested by 
trypsinization with trypsin/EDTA (Sigma-Aldrich, T4049). and pelleted bY 
centrifugation (1,500 rpm). 
3. The pellet cells were resuspended in 0.98ml PBS. IOVI FDA stock solution 
(IOOVg/ml in DMSO) and 10[tl PI stock solution (500[ig/ml in PBS) were 
added and produced aI ml cell suspension within I Vg/ml FDA and 5 Vg/ml PI 
by gentle vortex. 
4. The staining samples were incubated at room temperature for 30 min in 
darkness. 
5. The reaction was stopped by washing the samples twice with ice cold PBS. 
6. Stained cells were resuspended in 800ýtl PBS and the samples were protected 
from light at 4'C until flow cytometric analysis (in 24h). 
7. Samples were analysed immediately and not fixed. 10,000 events were 
acquired using the green channel FL I for FDA and the red channel FL3 for Pl. 
8. In order to setup the quadrant analysis, four controls were required for each 
individual experiment. They were cells in plain buffer, cells stained with FDA 
only, cell stained with PI only, and cells stained with both dyes. Electronic 
compensation was occasionally required to remove interference form the green 
emission in the red channel. 
9. On a FDA vs PI scatter plot, apoptotic cells should be double-negative, 
appearing in the lower left quadrant (LL). Necrotic cells or dead cells should 
be positive for PI only, and appear in the upper left quadrant (UL), while 
living cells should be positive for FDA only, appearing in the lower right 
quadrant (LR). 
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3.2.3.6 Annexin V-FITC 
Changes in the plasma membrane are one of the earliest features of apoptosis. In 
apoptotic cells, the membrane phospholipid phosphatidylserine (PS) is translocated 
from the inner to the outer leaflet of the plasma membrane, thereby exposing PS to the 
external cellular environment. Annexin V is a 35-36 kD Ca2'-dependent 
phospholipid-binding protein that has a high affinity for PS and binds to cells with 
exposed PS (Alison, 1999). Annexin V may be conjugated to fluorochromes such as 
FITC (fluorescein isothiocyanate) and PE (phycoerythrin). These formats retain their 
high affinity for PS and thus serve as sensitive probes for flow cytometry analysis of 
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Fillure 3-7: Schematic representation of the annexin V assay (from 
http: //www. bdbiosciences. com/image library/Annexin Assay. jpg) 
Because exterrialization of PS occurs at an early stage of apoptosis, staining with 
annexin V-FITC can identify apoptosis at an earlier stage than assays based on nuclear 
changes such as DNA fragmentation. Annexin V-FITC (Ann) staining precedes the 
loss of membrane integrity which accompanies the latest stages of cell death resulting 
from either apoptotic or necrotic processes. Therefore, staining with Ann in 
combination with propidium iodide (PI) allows the identification of early apoptotic 
cells (Ann+/Pl-) from those that are in the later stages of apoptosis or already dead 
(Ann + /Pl + ). Nevertheless, the assay does not distinguish between cells that have 
undergone an apoptotic death from those that have died as a result of a necrotic 
pathway, because both dead cell types will stain positively with both annexin V and PI 
(van Engeland et al., 1996). 
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3.2.3.7 Protocol of Ann/PI staining 
1. Cell culture procedures were identical with those described in protocol of 
FDA/Pl staining (steps I and 2). 
2. According to the protocol in the BD Pharmingen TM techincal data sheet 
(supplied with the agent: annexin V-FITC, BD 556420), the cell pellet was 
resuspended in binding buffer (prepared from annexin V binding buffer, IOx 
Concentrate, BD 556454). Then, 100ýd of cell suspension was transfered into 
a 5ml culture tube. 
3.5ýtl Ann and 10ýtl PI were added into the cell suspension, followed by gentle 
vortexing. 
4. The staining samples were incubated at room temperature for 15min in 
darkness. 
5. An additional 400[d of Ix binding buffer was added to each tube. 
6. Samples were analysed within I h. 10,000 events was acquired using the green 
channel FL I for Ann and the red channel FL3 for PI. 
7. In order to setup the quadrant analysis, four controls were required for each 
individual experiment. They were cells in binding buffer only, cells stained 
with Ann only, cells stained with PI only and cells stained with both agents. 
Electronic compensation was occasionally required to remove interference 
form the green emission in the red channel. 
8. In an Ann/PI scatter plot, living cells should be double-negative (lower left 
quadrant), apoptotic cells should be Ann positive (lower right quadrant), and 
dead cells or necrotic cells should be PI positive (upper left and upper right 
quadrants). 
3.3 Apoptosis results 
In the present project a lung cancer cell line (COR-L23) was selected to test the 
potency of the isolated compounds in apoptosis experiments. Lung cancer is the 
leading cause of cancer-related death (Blair et al., 1997). Its high prevalence, high 
death rate and ineffective current therapy have spurred the search for novel strategies 
in treatment of lung cancer. Two dual-colour fluorescent staining systems (Ann/PI 
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and FDA/PI) were applied in the present study for the detection of apoptosis. All 
measurements were made in triplicate and all values were represented as mean ± SEM 
(standard error of the mean). The results were subjected to an analysis of variance 
(ANOVA) using the Tukey's test to analyse the difference (p<0.05 were considered as 
significant). 
3.3.1 Positive control for bicolour- staining apoptosis assay 
An appropriate positive control for a bioassay is important. The agent must be able to 
induce apoptosis of certain cells and that ought to be detectable by the methods used. 
It is even better if the compound of positive control has a similar structure with the 
compounds in question. The compounds isolated from I. tectorum include two 
flavonoids: tectorigenin (24) and 7-0-methyl aromadendrin (66), and four iridal-type 
triterpenes: isoiridogermanal (57), iridobelamal A (60), IT4C (61) and IT41) (65). 
There is no literature about apoptosis induced by iridal-type triterpenes. However, 
some well known flavonoids with pharmaceutical activity, such as genistein and 
quercetin, have been reported to be able to induce apoptosis of human cancer cells 
(Vijayababu et al., 2006; Lian et al., 1999). 
Further literature research revealed that genistein was shown to induce cell cycle 
progression arrest at the G2/M phase and induce apoptosis in many different types of 
human cancer cell lines,, including breast, stomach, prostate and squamous cell 
carcinoma cell lines (Alhasan et al., 1999; Pagliacci et al., 1994; Matsukawa et al., 
1993; Kyle et al., 1997). Moreover, HPLC grade pure genistein is commercially 
available. Therefore, genistein was used as positive control for a methodological 
study of bicolour flow cy-tometry (FCM) analysis. 
Since these two bicolour staining systems (FDA/PI and Ann/PI) are based on different 
biological mechanisms, consistent results of two testing methods will be more reliable 
than a single method to confirm the induction of apoptosis. Practically, FDA is much 
cheaper than Ann, therefore it is preferable for the primary test of potent apoptotic 
compounds in a large scale screening. 
Firstly, the standard compound genistein (51) (Fluka 91955) was prepared in four 
concentrations from IOOpM to 400[tM, then incubated with COR-L23 cells for 48h 
before detection by FCM. The result of the present work showed that FDA/PI and 
Ann. /PI assays gave the same trend of dose response, which indicated significant dose- 
124 
Chapter 3 Activity of isolated compounds 
dependent apoptotic population of COR-L233 cells induced by genistein in a serial 
quadrant analysis. 
FDA/IPI assay of genistein (51) 
On the scatter plot of FDA (FLI) vs PI (FL3)) (Figure _33-8), apoptotic cells were 
double-negative, appeared in the lower left (LL) quadrant. Necrotic and dead cells 
were positive for PI only, and appeared in the upper left (UL) quadrant, while living 
cells were positive for FDA only, appeared in the lower right (LR) quadrant of the plot. 
When cells were under normal conditions, as shown on scatter plot A, most signals 
distributed in the LR quadrant representing 91% living cells. Signals in UL and LL 
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FilZure 3-8: Scatter plots of FDA/Pl-stalned COR-L23 (lung cancer) cells under three 
situations in quadrant analysis, they are living cells (LR), dead cells (UL) and 
apoptotic cells (LL), A: control; B: exposed tO 300gM genistein (51) for 48h 
The percentage of apoptotic cells increased and that of living cells decreased, when 
cells were exposed to 400ýtM genistein (51) for 48hr (scatter plot B in Figure 3-8). 
Signals in UL and LL quadrants represent 34.2% dead cells and 51.6% apoptotic cells, 
respectively. Meanwhile. only 14.2% living cells were left in LR quadrant. As seen 
in Figure 33-9, the proportion of apoptotic and dead cells increased with the 
concentration of genistein (51). These statistic results were obtained from a series of Z-- 
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Figure 3-9: Percentage of COR-L23 cells under three different situations after 
exposure to various concentrations of genistein (51) for 48h. Specimens stained with 
FDA/Pl (n=3) 
3.3.1.2 Annexin V-FITCIPI assay of genistein (51) 
As previously introduced, Ann/Pl assay gives quadrant results with different 
assignment. On a scatter plot of Ann (FLI) vs PI (FL-33), apoptotic cells will be Ann 
positive only (LR quadrant), living cells will be double negative (LL quadrant), and 
dead cells or necrotic cells will be PI positive (UL and UR quadrants). Practically, in 
the late stage of apoptosis, the dead cells should be positive to both agents, thus show 
up in UR quadrant. 
In this assay genistein (51) also induced dose-dependent apoptosis with 
concentrations over a range of 25ýtkl to 400ýM As seen in Figure 3-10, living cells 
(LL) decreased from 91.4% in control to 32.9% in 400ýM, meanwhile apoptotic cells 
(LR) increased from 2.9% in control to 18.4% in 400ýM The total dead cells (UL 
and UR) are also significantly increased from 5.8% in control to 48.7% in 400ýM 
Practically, the percentage of dead cells, which also increased with the concentration 
of genistein, could be attributed to both apoptotic as well as necrotic cells because 
genistein can induce necrosis at high concentrations (Baxa et al., 2005). Broadly, the 
result of the Ann/PI assay (Figure 3-11) are quite consistent with those of the FDA/PI 
assay. 
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Fillure 3-10: Scatter plots of Ann/Pl-stained COR-L2' 3 cells under three situations in 
quadrant analysis, they are living cells (LL), dead cells (UL and UR) and apoptotic 
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Filzure 3-11: Percentage of COR-L23 cells under three different situations after 
exposed to various concentrations of genistein (51) for 48h. Specimens stained with 
Ann/Pl (n=3) 
The alteration of DNA content distribution in COR-L23 cells induced by genistein (51) 
(Figure 3-12) shows a cell cycle-specific effect similar to that of vinblastine sulphate 
(69). The proportion of COR-L23) cells in G2/M phase gradually increased with the 
concentration of genistein (51). As shown in Figure 3-13). the cells in G-, /M phase 
increased from 17.2% in control to 337.5% at 200ýM On the other hand, cells in 
Go/G, phase decreased from 62.7% to 31%. However, the proportion of cells in S 
phase did not sionificantly change over the range of tested concentrations. A drop in 
B 
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proportion of cells in G2/M at 300ýM was observed at the end of the uptrend. This 
was mainly because that higher concentration of genistein (51) induced a rapid 
apoptosis, which caused the DNA degradation and sequentially lead to a large Z-- 
proportion of cell signals (33.6%) to move into the sub-G, DNA complement on the 
histogram of cell cycle analysis. 
Counts 
LýI--Fl 
Figure 3-12: Overlay histogram of cell cycle analysis for COR-L23 exposed to 
various concentrations of genistein (51) 
Apoptosis results of genistein (51) acquired from the two dual-colour staining assays 
are generally coincident to each other. The differences of the values between the 
counterpart treatments in two apoptosis assays are likely to be mainly due to the 
mechanism of the reactions, on which these bioassays are based. All the apoptotic 
results of genistein (51) were consistent with those in the literature (Matsukawa et al., 
19933; Salti et al., 2000; Po et al., 2002). This clearly indicated that the protocols of 
two dual-colour staining systems (FDA/Pl and Ann/Pl) followed in the present study 
were working as anticipated with the lung cancer cell line COR-L233. Thus, results of Z-- 
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Figure 3-13: Effect of genistein (51) on the cell cycle of CQR-L2-') cells after 48h 
expoSure (mean±SEM, n=3) 
3.3.2 Results for IT3Ac (24) 
There was no significant uptrend of dose-dependent apoptosis induced by tectorigenin 
(24) observed up to ImM in the two apoptosis assays (Figure 3-14 and Figure 3-15). 
It is thus suggested that tectorigenin (24) does not induce apoptosis in the COR-1_233 
cell line up to the very high concentration of ImM. This conclusion is indirectly 
supported by a recently published paper, in which tectorigenin (24) was demonstrated 
to protect against the cytotoxicity of HepG2 cells induced by tert-butyl hyperoxide 
(Lee et al., 2005). It was also suggested that the protection may originate from 
inhibition of apoptosis. Moreover, these findings lead support to the traditional use of 
the original plant, because Iris tectorum has been used to treat patients with hepatic 
cirrhosis. This activity could be explained by the presence of tectorigenin (24), 
isolated as a principal compound from the plant (Qin et al., 1996). 
On the other hand. tectorigenin (24) arrested cell progress at S and G-)/M phases (as 
seen in Figure 3-16 and Figure 3-17). Furthermore, this antiproliferative effectper se 
may cause a cell cycle-mediated drug resistance if it is used in a combination with 
other cell cycle-specific cytotoxic a(yents in an inappropriate sequence (Shah and 
Schwartz, 2001). 
129 




of cells 50% 
25% 
0% 
Ctrl 200 400 600 800 
Concentration (pM) 
El Lixing cells 
M Dead cells 
0 Apoptotic cells 
1000 
Figure 3-14: Percentage of COR-L23 cells under three different situations after 
exposure to various concentrations of tectorigenin (24) for 48h (Specimens stained 
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Figure 3-15: Percentage of CQR-L23 cells under three different situations after 
exposure to various concentrations of tectoriggenin (24) for 48h (Specimens stained 
with Ann/Pl, n=3) 
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Figure 3-16: Overlay histogram of cell cycle analysis for COR-L23 exposed to 
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Fif! ure 3-17: Effects of tectorigenin (24) on the cell cycle of CQR-L2') cells after 48h 
exposure (mean±SEM, n=3) 
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3.3.3 Results for IT2c (66) 
Both of FDA/Pl (Figure 3-18 and Figure -33-19) and 
Ann. /Pl (Figure 3-20 and Figure 
33-21) assays demonstrated that IT2c (66) induced apoptosis of COR-1-23 cells. In 
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Figure 3-18: Scatter plots of FDA/Pl-stained CQR-L2') cells under three situations in 
quadrant analysis; they are living cells (LR), dead cells (UL) and apoptotic cells (LL); 
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FiRure 3-19: Percentage of COR-L23 cells under three different situations after 
exposure to various concentrations of IT2c (66) for 48h (Specimens stained With 
FDA/PL n=3) 
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Filzure 3-20: Scatter plots of Ann/Pl-stained COR-L2-")' cells under three situations in 
quadrant analysis; they are living cells (LL), dead cells (UL and UR) and apoptotic 
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Fillure 3-21: Percentage of COR-L23 cells under three different situations after 
exposure to various concentrations of IT2c (66) for 48h (Specimens stained with 
Ann/Pl, n=3) 
Comparing with the distribution of cells in the control, the proportion of cells in S and 
G., /M phases did not change much when higher concentrations of IT2c (66) applied. Z-- 
However, this does not mean cells were not arrested or accumulated in certain cell 
cycle phase. Actually. the percentage of cells in histogram cyives result of a dj'nannc I Z-- t--I tý 
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cytotoxic agent applied, the more cells became apoptotic and dead, and therefore the 
sub-G I region increases from 6.2% in the control to 29.5% on treatment with I 00ýIM 
66 (data not shown). This implies that when more and more cells were being arrested 
at S and G2/Mphasesas compoundconcentration increased, at the same time some of 
them were also sequentially killed quickly by the compound. Thus, the quantitative 
result is the balance of a dynamic process. If this were not the case, the proportion of 
cells at S and G2/M phases should decline, rather than only reducing the proportion of 
cells in GO/Gj phase. 
A good example will be seen later in the results of IT4D (65) (Figure 3-28). In that 
case, no significant dose-dependent accumulation of cells in any cell cycle phase was 
observed. The proportions of cells in all phases decreased gradually when the 
compound concentration increased up to 60ýM Nevertheless, a drop of the 
proportion of cells in GO/Gj phase and relatively increased proportion in G-, /M phase 
with remarkably large error bars were observed on treatment with 100ýM 65. The 
reason is that most cells had already been damaged at such a high concentration of 
cytotoxic compound that only a limited quantity of cells was available for the cell 
cycle test. Thereby, the values from the treatment with I 00ýM IT4D (65) are unlikely 
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Figure 3-22: Effects of IT2c (66) on the cell cycle of CO. R-L2-)' cells after 48h 
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3.3.4 Results for IT4D (65) 
IT4D exhibited induction of apoptosis in both FDA/Pl (Figure 3-23) and Figure 3-24) 
and Ann/Pl (Figure 3-25 and Figure 3-26) assays. Also, it showed cell cycle non- 
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Fip_ure 3-23: Scatter plots of FDA/Pl-stained COR-L23 cells under three situations in 
quadrant analysis; they are living cells (LR), dead cells (UL) and apoptotic cells (LL); 
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FilZure 3-24: Percentage of COR-L2-')' cells under three different situations after 
exposure to various concentrations of IT4D (65) for 48h (Specimens stained with 
FDA/Pl. n=-')). IT4D (65) was tested for only three concentrations in the FDA/Pl 
assay. due to the limited amount of material. 
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Figure 3-25: Scatter plots of Ann/Pl-stained COR-L23 cells under three situations in 
quadrant analysis; they are living cells (LL), dead cells (UL and UR) and apoptotic 
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Figure 3-26: Percentage of COR-L23 cells under three different situations atter 
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Fiaure 3-27: Overlay histogram of cell cycle analysis for COR-L23 cells exposed to 
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Fiaure 3-28: Effects of IT4D (65) on the cell cycle of COR-L23 cells after 48h 
exposure (mean±SEM. n=3) 
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3.3.5 Fluorescence Microscopy 
Instruments used: 
Nikon ECLIPSER ' TE200 microscope (Nikon Vision Co.. Ltd. Tokyo. Japan) 
connected with Digital Camera DXM 1200. Software: LUCIA G Version 4.61 
for windows. 
* ZEISS Axioshop28 MOT plus microscope (Carl Zeiss Co.. Ltd, Welwyn 
Garden City, UK); images recorded at multiple wavelengths using a Digital 
Camera: Zeiss AxioCarn HRC. Software: Axiovision for windows. 
Observations: 
The morphological appearance of COR-L23 cells growing under normal condition 
(control) in a 6-well plate is shown as Figure 3-29, an image taken with neutral light. 
In this view cells are seen to be well attached to the surface of the plate, forming a 
confluent monolayer, and in which numerous mitotic cells can be observed. Another 
image (Figure 3-30) shows the morphological characteristics of apoptotic COR-L23 
cells induced by 125[tM IT2c (66). As indicated by the arrows (Figure 3-30), the 
presence of the formation of apoptotic bodies and cell shrinkage are highlighted by 
means of phase contrast-2 microscopy. When cells were observed with this function 
of microscope, the detached apoptotic cells stand out and can readily be distinguished 
from the living cells in the background. 
After the dual-colour fluorescent assays by FCM, the remaining cells were observed 
under a fluorescence microscope. Figure 3-31 shows the apoptotic cells induced by 
125ýtM IT2c (66) and stained with FDA/PI. Because the apoptotic cells were double 
negative to both dyes (FDA-/Pl-), darkfield microscopy was applied to take this 
multichannel image. Therefore, apoptotic cells appeared as a mass of bright dots, 
which only gives the profile of cells without any fluorescence (indicated by arrows). 
Meanwhile, living cells are shown as the overlay of green fluorescence and bright 
dots acyainst the dark background. Red fluorescence with bright dots indicates dead r-7- 
cells. 
Apoptotic cells induced by 8OpM IT4D (65) are seen as bright green in Ann/PI systern 
as illustrated in Figure 33-332. Noticeably, the apoptotic cells in this view were 
undergoing mitotis and the division was not completed. The dead cells (indicated bv 
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arrows) appear as an orange colour because of the overlay of green and red 
fluorescence. That might be a result of late apoptosis. Cells shown in pure red 
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Figure 3-29: Microscopic image of CQR-L2') cells after incubation in growth 
medium for 48h as control (taken with neutral light and phase contrast- I at x40 b 
Ni 
Fi, c. Fure 3-30: Microscopic image of COR-L23 cells after exposure to 125 1 IT2c (66) 
for 48h (taken xvith neutral li(, N and phase contrast-2 at x40 by Nikon ECLIPSE' 
T E2 0 0) 
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Figure 3-31: Fluorescent microscopic image of COR-1-23 cells after exposure to 
125[ýM IT2c (66) for 48h and stained with FDA/PI (taken as multichannel imav-e with 
a view of Darkfield at x40. bv ZEISS Axioshonf"' MOT -olus) 
Fiaure 3-32: Fluorescent microscopic imagge of COR-L23 cells after exposure to 
80LIM IT4D (65) for 48h and stained with Ann/Pl (taken as multichannel image at 
x40. by ZEISS Axioshoplo'MOT plus) 
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3.3.6 Summary and Conclusion 
The measurements of cell cycle analysis were made in triplicate and all values are 
presented as mean ± SEM (Standard Error of the Mean). These results were subjected 
to an analysis of variance (ANOVA) using Dunnett's test to compare all treatments 
with control as seen in Table 3-6. 
Statistical tests of cell cycle analysis confirmed that the positive controls, vinblastine 
sulphate (69) and genistein (51), as expected, significantly arrested COR-L23 cells at 
G2/Mphaseup to 45nM and 200ýM, respectively. Although it has been previously 
reported that genistein (51) induced cell cycle progression arrest at S and G2/Mphases 
in human head and neck squamous cell carcinoma cell line (Alhasan et al.. ) 
1999). no 
significant increase in S phase was observed over a range of concentrations from 
20[tM to 300ýM in the present work. After exposure to genistein (51) for 48h, 
significant cell accumulation was only shown in the G2/M Phase at concentrations of 
80ýM, 120ýM and 200[tM. There is significant accumulation of cells in S and G2/M 
phases induced by tectorigenin (24) at 400ýM and 600ýM As to IT2c (66). COR- 
L23 cells were significantly arrested in S phase at 60ýM and 100[tM, but no 
significant accumulation was observed in the G2/Mphase. Although the cell 
proportion did not increase significantly in G2/Mphase, the cell proportions are still 
keeping in relative high levels of 18.1% and 17.9% at 40ýM and 60VM IT2c (66), if 
compared it with that of IT41) (65) (where cells proportions in all phases reduced 
much lower than that of control). This statistical analysis, however, can not rule out 
the possibility of IT2c (66) inducing cell cycle progress arrest in both S and G2/M 
phases. The result of IT4D is rather simple - cell proportions are reduced in all cell 
cycle phases. The decline in GO/Gj and S phases are significant, whilst the percentage 
of cells in G2/Mphasekeeps in lower level than that of the control. This means that 
cells were killed by IT41) at all stages of cell cycle. 
The percentage of apoptotic cells calculated by quadrant analysis (either FDA_/Pl_ or 
Ann+/PF) is summarized for each treatments as shown in Table 3-7. Moreover. these 
data were also compared between every two treatments of each compound detected by 
the same assay (shown in Table 3-8 and Table _3-9). 
Statistical significances of 
difference between every two values of apoptotic rate were subjected to One--ýX'ay 
ANOVA xvith Tukey"s Multiple Comparison post test, ,, x-hich is a built-in statistical 
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application of the programme GraphPad Prism version 4 for Windows (GraphPad 
Software, San Diego California USA). In addition, the significance is classified into 
four levels, which are shown as: - (p>0.05), + (p<0.05), ++ (p<0.01) and 
(p<0.001). 
According to the quadrant analysis data (Figure 3-9 on page 126) and the statistical 
results of genistein (51) (Table 3-8), the proportion of apoptotic cells significantly 
(p<0.001) increased with the concentration of genistein (51). These results indicate 
significant dose-dependent apoptosis in both dual-colour apoptosis assays. In 
addition, genistein (51) efficiently arrested COR-L23 at G2/Mphaseofcell cycle, as 
did vinblastine. This conclusion is consistent with those in the literature (Baxa et al., 
2005; Alhasan et al., 1999). 
However, the trend implied by the result of tectorigenin (24) is not as clear as that of 
genistein (51). Although the apoptotic results of treatments significantly differ from 
that of control (p<0.001), there is poor significance of difference between any other 
treatments,, especially when comparing the results of high concentration with those of 
low concentration, such as 200ýtM vs ImM and 400ýtkl vs ImM (p>0.05) in the 
FDA/PI assay. Moreover, the statistical analysis of Ann/Pl assay clearly indicates that 
no significant difference between any two treatments. The statistical results of both 
dual-colour apoptosis assays suggested that up to 1,000ýtM tectorigenin (24) did not 
significantly induce dose-dependent apoptosis of COR-L23 in 48h. This conclusion is 
contrary to a finding, in which it was claimed that tectorigenin (24) did induce 
apoptotic changes of DNA in human promyelocytic leukaemia HL-60 cells (Lee et al., 
2001). It also reported the IG50of tectorigenin (24) and genistein (51) against HepG2 
cell line were 84ýtM and 39.9pM, respectively. Interestingly, the results of genistein 
(51) in the present study are fairly consistent with those of the previous report-, 
however, the observed bioactivities of tectorigenin (24) are different with those in 
literature. The main reason for the different conclusion about the apoptotic effect of 
tectorigenin (24) could be due to the difference of cell lines, experimental conditions 
and the assays applied. For instance, in the previous research, the cytotoxicity assay 
carried out by MTT assay and the induction of apoptosis in promyelocytic leukaemia 
HL-60 by tectorigenin (24) for four days (96h) was detected only by means of cell 
cycle analysis assay with FCM and no cell cycle specific cytotoxicitN, ýN-as observed. 
That is not a specific assay for apoptosis indeed. In present study. the cell qcle 
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analysis result of tectorigenin (24) clearly indicated that it is able to arrested COR- 
L23 cells at S and G2/Mphases at certain concentrations. This is the first such 
reported observation for tectorigenin (24). 
As seen in Table 3-7 and Table 3-9 , in the result of FDA/Pl assay for IT2c (66). the 
proportion of apoptotic cells significantly (p<0.001) increased with the concentration 
of IT2c (66). This indicates significant dose-dependent apoptosis in COR-L2-'). 
However, because of the limited amount of pure compound, the Ann/Pl assay of IT2c 
(66) was carried out with concentrations up to 100ýM. Statistical analysis shows the 
apoptotic rate of 100ýM significantly differs from that of control (p<0.01) and 25ýM 
treatment (p<0.05). The overall result of IT2c (66) suggests that it is a medium 
cytotoxic flavonoid that can induce apoptsis of COR-L23 ) in vitro. Also, it might be 
able to arrest COR-L23 cells at S and G2/Mphases, as did tectorigenin (24). 
Unfortunately because of lack of sample, the FDA/Pl assay of IT41) (65) was only 
carried out for concentrations up to 60ýM (as shown in Table 3-9). The dose- 
dependent apoptosis can still be observed significantly when comparing the value at 
60ýtM with that of control and other concentrations (p<0.01). On the other hand, the 
Ann/Pl assay (see Table 3-9 and Figure 3-26 on page 136) gave a significant increase 
of apoptotic rate with the concentrations of IT4D (65) (greater than 60[tM). These 
observation suggest that IT4D (65) significantly induce apoptosis of COR-1-23 cells at 
60ýtkl and higher concentrations (up to I 00ýM). 
The activities of the compounds tested against COR-L23 cell line are summarized as 
Table 3-5, in which the cytoxicity and apoptosis activity of IT2c (66) and IT4D (65) 






Cell cycle phase 
specificity 
genistein (51) 62.7±8.98 Yes G2/M 
tectorigenin (24) 189_3±6.55 No S and G2/M 
IT2c (66) 33 2.8 ± 0.5 0 Yes S and G2/M 
luteolin (22) 11.0±0.67 
IT4C (61) _34.8 ± 
0.8 6 
IT4D (65) 19.0±0.44 Yes Non-specific 
IT4E (60) 133.9±0.27 
IT4F (57) 15.7±1.84 
Table 3-5: Summary of results of compounds tested 
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Compounds Con Cell cycle distribu-tion (%) in COR-L23 cell line c. GO/GI S G2/M 
OnM 61. ) ±0.60 13.8 ±0.19 15.7 ±0.18 
1.5nM 56.9 ±0.96** 10.3 "' ±0.17 26.5 ±0.13 
vinblastine 4.5nM 16.0 ±0.49** 6.1 ±0.15** 55.2 ±1.07** 
sulphate (69) IOnM 4.6 ±0.13** 6.0 ±0.3 )0** 66.0 ±1.68** 
15nM 5.5 ±0.10** 3.6 ±0.06** 73.7 ±1.16** 
45nM 5.8 ±0.06** 3.7 ±0.05** 71.3 ±0.81 
Oýtm 62.7 ±0-68 14.3 ±0.17 17.2 ±0.79 
20ýM 44.5 ±1.06** 11.2 ±1.20 16.0 ±1.32 
40ýM 43.7 ±2.1 1 ** 11.2 ±1.28 19.8 ±1.02 
genistein (51) 80ýtm 34.5 ±3.92** 14.8 ±2.34 34.5 ±0.90** 
120ýM 33.6 ±3.88** 12.6 ±2.10 37.4 ±1.4-2 
200[tM 31.0 ±3.27** 11.0 ±2.31 37.5 
300ýtM 29.9 ±4.80** 15.7 ±2.88 19.2 ±0.77 
Oýtm 62.7 ±0-68 14.3 ±0.17 17.2 ±0.79 
50ýtM 46.9 ±1.69** 11.1 ±0.41* 133.6 ±0.26 
tectorigenin 
I 00ýtm 45.9 ±1.39** 
** 
11.2 ±0.32* 15.1 ±0.07* 
(24) 200[tM 43.5 ±1.88 12.5 ±0.66 18.6 ±0.12 
400ýtM 31.7 ±1.60** 16.6 ±0.72 26.1 ±0.75** 
600ýtM 28.6 ±1.24** 20.4 ±1.16** 22.2 ±0.39** 
800ýtm 34.8 ±1.84** 15.6 ±1.22 17.1 ±0.49 
Oýtm 62.7 ±0.68 14.3 ±0.17 17.2 ±0.79 
IOPM 48.4 ±1.85** 12.3 ±0.17** 14.0 ±0.45* 
20pM 47.6 ±1.79 ** 12.6 ±0.52** 14.6 ±0.18* 
IT2c (66) 30ýtM 46.3 ±1.53** 13.3 ±0.12 15.8 ±0.45 
40pM 43.3 ±1.92** 14.5 ±0.15 18.1 ±0.63 
60pM 37.5 ±2.40** 18.3 ±0.17** 17.9 ±0.76 
100ýtm 35.9 ±3.75** 18.2 ±0.49** 16.8 ±0.71 
OýIm 62.7 ±0.68 14.3 ±0.17 17.2 ±0.79 
IOPM 49.2 ±2.08 10.9 ±1.02** 13.0 ±1.16 
20pM 47.7 ±1.94 11.5 ±1.06 * 13.5 ±0.80 
IT4D (65) 30ýiM 4 7.6 ±1.8 1 10.9 ±1.06** 13.8 ±0.69 
40pM 46.9 ±2.48 10.6 ±0.95** 13.3 ±0.45 
60pM 45.4 ±3.24** 6.9 ±0.70** 10.3 ±0.40 
I OOPM 24.2 ±8.62 7.5 ±1.96 15.3 ±3.79 
Table 3-6: Distribution of COR-L23 cells in three cell cycle phases after exposure to 
various concentrations of compounds (Percentage ± SEM, n=3; comparison: values 
not significantly different with that of control are listed without mark, R<0.05 is 
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Chapter 4 Prodrug screenin, o 
CHAPTER 4 
PRODRUG SCREENING 
Generally, a prodrug is an inactive precursor of a drug, converted into its active form 
in the body by normal metabolic processes (Syrigos and Epenetos. 1999). The use of 
a prodrug strategy increases the selectivity of the drug for its intended target. This can 
be seen in many anticancer treatments, in which the reduction of adverse effects is 
always of paramount importance (Connors, 1995). For instance, irinotecan (71) is an 
anticancer prodrug that has been approved for the treatment of colon cancer. It is a 
member of the camptothecin class of drugs and mediated by carboxylesterases to the 
active metabolite SN-38 (72) at the tumour site and inhibits tumour cell growth by 
inhibiting topoisomerase I (Hyatt et al., 2005). Since the prodrug has low cytotoxicity 
prior to this activation, there is a markedly lower chance of its "attacking" healthy, 













Chapter 4 Prodrugscreening 
Besides synthetic compounds, prodrugs may also occur naturally. Sometimes the use 
of a prodrug is unintentional, especially in the case of serendipitous drug discoveries 
from natural products, and the drug is only identified as a prodrug after extensive drug, 
metabolism studies. For example, artemisinin (73) is a sesquiterpene lactone isolated 
from a well known TCM: Artemisia annua L (Klayman, 1985). This natural product 
and its analogs are being used as antimalarials. Nevertheless it was discovered to be 
more toxic to cancer cells than to normal cells (Lai and Singh, 1995; Singh and Lai, 
2001). Further research has shown that arternisinin induces apoptosis in cancer cells 
(Singh and Lai, 2004). The cytotoxic mechanism was discovered that arternisinin 
reacts with iron and forms intracellular free radicals, which could cause 
macromolecular damage and lead to cell death (Efferth et al.,, 2004). Since cancer 
cells uptake relatively larger amount of iron than normal cells, they are therefore more 
susceptible to the toxic effect of artemisinin. This selective cytotoxicity towards 
cancer cells can be further enhanced by tagging arternisinin to the iron-carrying 
plasma glycoprotein transferrin. Because transferrin is transported into cells via 
receptor-mediated endocytosis and cancer cells express significantly more transferrin 
receptors on their cell surface and endocytose more transferrin than normal cells. 
After entry to the cell, iron is released and can readily react with arternisinin tagged to 
the transferrin. Thus, this tagged-compound could potentially be developed into an 









Chapter 4 Prodruýi screening 
4.1 Possible prodrug mechanism within TCM 
As most traditional medicines are administered orally, their components inevitabl\- 
come into contact with intestinal microflora in the alimentary tract. Most of the 
components are transformed by intestinal bacteria before being absorbed from the 
gastrointestinal tract (Akao et al., 1994; Kim et al., 1998a). Practically. most TCM 
are traditionally used as decoctions, which is in rich of water soluble compounds, 
such as glycosides. Furthermore, an intensive study clearly point out that antiplatelet 
activity and cytotoxicity of the metabolites of flavonoid glycosides by human 
intestinal bacteria were more effective than those of the parental compounds. For 
instance, quercetin (74) and ponciretin (75) were more effective than rutin (23) and 
poncirin (76) on the cytotoxicity against a number of tumour cell lines, respectively 
(Kim et al., 1998). 
In previous research, tectorigenin (24) was isolated from Pueraria thunbergiana (a 
TCM to treat diabetes mellitus) together with structurally related compounds: 
tectoridin (25) and 6"-O-xylosyltectoridin (77) (Bae et al., 1999). Further 
experiments revealed that the relatively hydrophilic isoflavones, tectoridin and 6"-0- 
xylosyltectoridin, can be efficiently transformed into tectorigenin (a rather 
hydrophobic compound) by some human intestinal bacteria, such as Bifidobacterium 
breve k-110 and Eubacterium A-44 (Kim et al., 1998a) (see Figure 4-1). The 
transformed tectorigenin showed more potent hypoglycernic activity, anaphylaxis 
inhibitory activity and cytotoxicity against tumour cells than its glycoside (tectoridin) 
(Park et al., 2004; Bae et al., 1999). 
Another experiment suggested that luteolin- 7- O-gluco side (50) was absorbed after 
hydrolysis to luteolin (22) by bacteria on the surface of the intestinal mucosa (Shimoi 
et al., 1998). This hydrolysis process was also demonstrated by using fl-glucosidase 
in iltro (Gebhardt, 2002). 
All the previous reports strongly suggest that some glycosides especially flavonold 
glucosides should be considered as natural prodrugs in traditional medicine, and that 
they can be transformed into active compounds by human intestinal bacteria. 
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Chapter 4 Prodrug screening 
4.2 Enzymatic hydrolysis assay 
It has been confin-ned that flavonoid glucosides can be efficiently transformed into the 
active aglycone (the corresponding flavonoid) by some human intestinal bacteria 
(Park et al., 2004; Bae et al., 1999). However, the procedure of reaction mixture 
involved bacteria is difficult to combine with cell culture test as a high throughput 
prodrug assay, because contamination with bacteria can affect the cell growth. and 
metabolism requires fairly long time preincubation (12h with intestinal bacterial 
strains or 2 days with fresh human faeces) (Kim et al., 1998). 
A cytotoxicity assay with enzymatic hydrolysis procedure was established in this 
project to discover potential P-glucosides as prodrugs in crude extracts of TCMs. This 
experiment is based on the fact that the similar hydrolysis reaction of fl-glucoside 
flavonoids would happen in vivo. Beside the relative enzymes produced by intestinal 
flora, a broad specific P-glucosidase has been found in human organs and 
characterized,, such as the cytosol of liver (Daniels et al., 1981). Moreover, the acidic 
environment in the digestive tract also contributes to the hydrolysis of flavonold 
glycosides in vivo. Meanwhile, the in-vitro enzymatic hydrolysis assay is limited by 
the availability of purified enzymes. 
P-Glucosidase is an enzyme which catalyzes the hydrolysis of various compounds 
with P-D-glucosidic linkages. It has been isolated from fungi, bacteria, yeast and 
plants (Shewale, 1982). This enzyme was employed in the present prodrug assay 
because about half of the naturally occurring flavonoid glycosides are fl-D-glucosides 
(Mabry, 1970). The fi-glucosidase from almonds was commercially acquired from 
Sigma-Aldrich (Fluka 49290, >6 units/mg, lU corresponds to the amount of enzyme 
which liberates I ýtmol glucose per minute at pH 5.0 and 35'C). The advantages of 
this enzyme including: high efficiency, non-toxic effect on cells and low cost. 
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4.2.1 Positive Control of prodrug assay 
A previous publication revealed that luteolin-7- O-gl uco side (50) a P-D-glucoside can 
be efficiently hydrolysed to luteolin (22) by fl-glucosidase (Nusslein and Kreis. 2000, 
Gebhardt, 2002). An absorption analysis using rat everted small intestine also 
demonstrated that luteolin- 7- O-gluco side (50) was absorbed as the aglycone after 
hydrolysis to luteolin in digestive tract. An HPLC analytical method in the literature 
(Shimoi et al., 1998) allowed easy separation of luteolin- 7- 0- gluco side (50) (RT 
12.8min) and luteolin (22) (RT 22.8min). Thus, as the precursor of luteolin (22). 
luteo lin- 7- O-gluco side (50) was obtained from Extrasynthese (1126S) and tested as 
the positive control in the prodrug assay. Luteolin (22) was obtained from Sigma- 










4.2.2 Optimization of prodrug assay 
OH 
OH 
Basically, P-glucosidase is a non-toxic agent. With 4mg/ml of it in medium, 77% of 
cancer cells were still growing after 48h. When 0.5mg/ml fl-glucosidase added into 
medium, the inhibition of cell proliferation caused by the enzyme was no more than 
4% (see Figure 4-2). An extra experiment indicated that 0.5mg/ml was as effective as 
2mg/ml fl-glucosidase for the hydrolysis of luteolin- 7- O-gluco side (50) to luteolin in 
this prodrug assay (data not shown). Thus, the following prodrug assay was carried 
out with 0.5mg/ml P-glucosidase. 
The cytotoxic effect of the positive control against cancer cells was tested after an 
exposure time of 48h. Luteolin (22) exhibited IG50 of lIpM against COR-1-23) cells. 
On the other hand, luteolin-7-0-glucoside (50) is a relatively non-toxic compound. 
154 
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since there is still 77% proliferation of cells with 200ýtM luteolin-7-0-glucoside (see 
Figure 4-3). When incubated with #-glucosidase, luteolin-7-0-glucoside (50) 
exhibited cytotoxicity with IG50 of 335.7ýM (see Figure 4-3). This obsen7ation is 
consistent with that in the literature (Gebhardt, 2002) and clearly demonstrated that 
luteolin-7-0-glucoside (50) was hydrolyzed to luteolin (22) by 0.5mg/ml fi- Z-1 
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Figure 4-3: Comparison of dose-dependent cvtotoxicitN,, of luteolin (LUT) (22) "'vith 




Chapter 4 Prodrug screening 
As positive controls luteolin-7-0-glucoside (50) and luteolin (22) were tested b\- this 
prodrug assay in a pattern for all the other samples. As shown in Figure 4-4. cancer 
cells were treated with identical molar concentrations (15ýM and 100ýM) of luteolin 
(22) and luteolin-7-0-glucoside (50), respectively. Firstly, both compounds were 
prepared in normal medium, P-glu(-), and, as a counterpart experiment, they were 
prepared in medium with 0.5mg/ml P-glucosidase, P-glu(+). After preincubated at 













Ctrl 1,7(1-15W L7G-100ýM I. LIT-15pM LUT-IOOpM 
Figure 4-4: Comparison of cylotoxicity of luteolin-7-0-glucoside (L7G) (50) and 
luteolin (LUT) (22) in prodrug assay (mean±SEM, n=2) 
The number of cells in the control (those growing in medium only, with or without#- 
glucosidase) was calculated as 100% remaining cells. The proportion of remaining 
cells as a function of drug concentrations was observed and the cytotoxic activity of 
luteolin (22) calculated. The results were consistent to each other in two sets of 
luteolin (22) experiments tested with medium of P-glu(+) and #-C'lu(-), the cells 
remaining reduced from about 60% in 15ýtM to 20% in 100ýiM luteolin (22). On the 
other hand, without the presence of fl-glucosidase, 102% and 95% cells remained 
within 15ýM and 100[tM of luteo I in- 7- O-gluco side (50), respectively. Howe-ver. 
luteolin-7-0-glucoside (50) exhibited significant (P<0.01) dose-dependent Z: ý 
cytotoxicity against lung cancer cells in the P-glu(+) experiment. Furthermore. its L- 1=1 
inhibition potency was very similar to that of luteolin (22). The remaining cells 
declined from 54% to 17% NA-hen the concentration of luteolin-7-0-, cylucoside (50) was L- 
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increased from 15ýM to 100ýtM in the P-glu(+) experiment. These observations 
suggested that luteolin- 7- O-gluco side (50) was hydrolyzed to luteolin (22) by fl- 
glucosidase in the medium, so that it showed the same cytotoxicity as luteolin against L- 
cancer cells. That means fl-glucosidase worked as a key to activate the cytotoxicity of 
prodrug in this prodrug assay. 
4.2.3 Protocol of enzymatic hydrolysis: 
This procedure was previously established by Gebhardt, 2002 and was modified in the 
present work. 
1. fl-Glucosidase was dissolved in cell culture medium to obtain aI mg/ml 
solution. 
2. The crude plant extract was dissolved in the medium with lmg/ml of fl- 
glucosidase to obtain a range of desirable concentrations, which were made as 
double of the final concentrations for test. All solutions were sterilized inside 
the laminar-flow hood by filtration through a 0.22nM filter before incubated 
with cells. 
3. After I hour preincubation at 37'C, the hydrolyzed solutions were added into 
96-well plates. The final solutions were obtained by adding drug solutions 
into 96-well plates for 100ýtl per well (mixed with the original 100ýtl growing 
medium in each well). 
4. The final concentrations of drug solutions thus obtained were 100ýtg/ml and 
200ýtg/ml in wells (pure compounds prepared as 100ýM and 200ýM)- 
Meanwhile, fl- glucosidase became 0.5mg/ml in each well. The solutions for 
negative control were made with only medium and, 8- glucosidase. 
4.2.4 Results of prodrug assays 
All water and MeOH extracts involved in this project were tested by the enzymatic 
hydrolysis assay. Because the raw materials were extracted continuously by hexane. 
CHC13, MeOH and water. the flavonoid glucosides in question are very likely to be 
concentrated into MeOH and water extracts. Therefore, the prodrug assay was carried 
out only on all the MeOH and water extracts of TCMs. The extracts were prepared at 
100ýtg/ml and 200pg/ml to detect possible dose-dependent cytotoxicity. which might 
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be noticeably changed by hydrolysis by P-glucosidase. 
Comparing with the control, the water and MeOH extracts of Gekko sit'inhonis (GK). 
Ifficium verum (IV) and Dolichos lablab (DL) did not exhibited cytotoxicity against 
COR-1-23 cells after 48h exposure. The remaining cells were higher than 88% after 
exposure to those extracts. Also, no significant difference observed between the 












Fiizure 4-5: Prodrug screening for crude extracts of Gekko swinhonis (GK), Illicium 
verum (IV) and Dolichos lablab (DL) (mean±SEM, n=2; a-glu= #-, glucosidase) 
Although the water extracts of Iris tectorum (Iris-water-100 and Iris-water-200) did 
not show cytotoxicity, its MeOH extracts (Iris-MeOH-100 and Iris-MeOH-200) 
exhibited dose-dependent cytotoxicity against COR-L233 in 48h. The remaining cells 
decreased from 78% in 100ýtg/ml to 64% in 200ýtg/ml, for fl-glu(-) experiment. 
Moreover, the same extracts showed slightly increased activity in an experiment with 
olucosidase in the medium. The remaining cells were 73% in 100ýtg/ml and 53% in P- L_ L_ 
200pg/ml, respectively, for P-glu(+) experiment (see Figure 4-6). However, the 
difference caused by fl-glucosidase was not statistically significant in this test. 
The result of prodrug screening for Lonicera japonica showed that both water and 
MeOH extracts showed dose-dependent cytotoxicity. In #-glu(-) experiment. the 
remaining cells decreased from 79% in LJ-water-100 to 17% in LJ-water-200. and : _1 
from 78% in LJ-MeOH-50 to 11% in LJ-MeOH-200. Ho,, vever. the extracts 
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demonstrated much lower cytotoxicities in fl-glu(+) experiment than that of #-, C'Iu(-) 
experiment. Remarkably, the remaining cells in 200ýtg/ml LJ-MeOH significantly 
increased (p<0.0 1) from I I% in fl-glu(-) to 54% in P-glu(+) (see Figure 4-7). This 
observation suggests a detoxification reaction caused by addition of P-glucosidase in 
the tested solution of LJ-water and LJ-MeOH extracts. This unexpected result is 
interesting and worth clarification in future research work. 
00 
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Fip_ure 4-6: Prodrug screening for crude extracts of Iris tectorum (mean±SEM, n=2) 
3 
ýxAoý Co 
Figyure 4-7: Prodrug screening for crude extracts of Lonicera japonica (mean±SEM. 
n=2) 
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CHAPTER 5 
DISCUSSION 
Plants have a long history of being used in the treatment of cancer. A survey of plants 
used in ethnomedicine against cancer has revealed more than 3-3350 plant species 
(Graham et al., 2000). The introduction of active compounds derived from nature 
into the cancer treatment has changed the natural history of many types of human 
cancer. Experimental agents derived from natural products offer a great opportunity 
to evaluate not only totally new chemical classes of anticancer agents, but also novel 
and potentially relevant mechanisms of action (da Rocha et al., 2001). 
However, the research for novel anticancer compounds from ethnobotanical sources 
can not be readily carried out. In many instances, "cancer" is undefined,, or reference 
is made to conditions such as "hard swellings", abscesses, calluses, corns, warts, 
polyps, or tumours, to name but a few. Many of such symptoms indeed sometimes 
correspond to a cancerous condition, but many of the claims for efficacy should be 
viewed with some scepticism. Cancer, as a specific disease entity, is likely to be 
poorly defined in terms of folklore and traditional medicine (Cragg and Newman, 
2005). 
On the other hand, development of modem medicine is aimed to explore the 
specificity of morbidity, whereas TCM theory usually implies that the cures of non- 
specificity sometimes could influence or change the process of morbidity (Lu et al., 
2004). TCM practitioners regard disorder to be caused by the disturbance in any part 
of the self-controlled system in the integrity (human body). Furthermore, the 
determination of treatment is based on pathogenesis obtained through differentiation 
of symptoms and signs (Jia et al., 2006). As to anticancer treatment, TCM therapy is 
described as a multi-way, multi-layer and multi-target integrated treatment 
characterized by "survival with tumour" and improvement in quality of life (Que et al.. 
2005). An ideal result of the TCM therapy for cancer should be a positive response of 
the patient with satisfactory quality of life and increased survival time. Thus. the 
diagnosis and treatment of TCM is based on a different theory, which focuses on the 
result of treatment rather than a definite biomedical mechanism. 
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5.1 Prodrug screening 
It should not be a surprise if a traditional medicine with good reputation in local 
culture does not exhibit any activity in screening by in-vitro bioassays. That means it 
is not guaranteed to isolate individual compounds with high bioactivity from the 
natural anticancer medicine. Besides the possibility of synergistic effects of the 
components within a TCM prescription, the metabolic process in human body after 
oral administration should not be ignored upon the investigation of bioactiVe 
compounds in TCM. Generally, most traditional medicines are administered orally so 
that the components of these medicines inevitably come into contact with microflora 
in the alimentary tract. Some TCM components could be transformed by intestinal 
bacteria before being absorbed from the intestine. It has been reported that intestinal 
bacteria can hydrolyze glucosides of flavonoids and produce aglycones (Hawksworth 
et al.,, 1971; Kang et al., 2005). Thus, a prodrug assay associated with a hydrolysis 
enzyme was carried out in present study. 
Although no further isolation followed the prodrug assay because of lack of time, the 
result really provided useful information for the feasibility and necessity of using it as 
a routine screening assay for investigation of natural medicines. According to 
previous research, luteo lin- 7- O-gluco side (50) was hardly absorbed by itself and it 
was absorbed after hydrolysis to luteolin (Shimoi et al., 1998). In the present prodrug 
assay, luteolin- 7- O-gluco side (50) did not show cytotoxicity against COR-L23 cells 
and allowed 77% proliferation of cells at 200ýM Nevertheless, it exhibited relatively 
strong cytotoxicity with IG50 of 35.7ýM after hydrolysis by fl-glucosidase. Therefore, 
the activity of potent compounds like luteolin is unlikely to be detected by in-vitro 
screening when it is still in the form of the corresponding glucoside such as luteolin- 
7-0-glucoside (50) in TCM. 
The prodrug assay for crude extracts showed that no cytotoxicity was observed in 
those treatments by crude extracts of Gekko swinhonis, Illicium verum and Dolichos 
lablab (see Figure 4-5). There was no significant difference of the activity observed 
after those extracts incubated with fi-glucosidase either. At the same time, hwxever. 
the MeOH extracts of Iris tectorum showed dose-dependent activity. Moreover. its 
water extract (at 200pg/ml) and MeOH extract (at 100pg/ml and 200ýlg/ml) sho%\Cd 
increased cytotoxicity after incubation , vith fi-glucosidase (see Figure 4-6). 
This 
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difference of activity is likely to be caused by the hydrolysis of glucosides 
components (less active) into their active aglycones in this TCM. Interestingly. the 
water and MeOH extracts of Lonicerajaponica showed dose-dependent cytotoxicity. 
However, both extracts exhibited significant decrease of cytotoxicitý, in experiment 
with fl-glucosidase in medium (see Figure 4-7). This unexpected result suggested that 
the integrated effect of a TCM can not readily be described thoroughly by in-vitro 
assays. As a mixture of many components the final metabolites may exhibit higher 
activity or lower activity in vitro. Before a further investigation, the mechanism 
behind the decreased cytotoxicity of extracts of Lonicera japonica caused by fl- 
glucosidase is not clear. 
5.2 Bioactivity of flavonoids from natural products 
Flavonoids are one of the most widespread classes of plant secondary metabolites. 
They usually occur as glycosides rather than as aglycones (Zielinska et al., 2003). 
More than 4,000 flavonoids have been isolated (Dugo et al., 2005). Many flavonoids 
occur in the human diet, such as flavones in grains and herbs, flavonols and their 
glycosides in fruits and vegetables, flavanones in citrus juices, isoflavones in legumes 
and catechins in tea (Peterson and Dwyer, 1998). 
These polyphenolic components are known as excellent antioxidants in vitro. They 
have been shown to prevent lipid peroxidation, to scavenge reactive oxygen species, 
to chelate iron ions (essential for the generation of hydroxyl radicals) and to inhibit 
NADPH-dependent oxidases and consequently superoxide anion production 
(Catapano, 1997; Rice Evans et al., 1997; Robak and Gryglewski, 1996). 
Epidemiological studies have suggested that a diet rich in isoflavonoids may play an 
important role in cancer prevention (Markovits et al., 1989; Messina et al., 1994). 
Further studies of the soybean phyto-oestrogens genistein (51) and daidzein (78) 
suggested that these flavonoids affect cancer progression as a result of their effects on 
apoptosis, cell cycle progression, growth and differentiation as well as their 
antioxidant and antiangiogenic effects (Constantinou et al., 1990: Yamashita et al., 
1990, Okura et al.. 1988, Menon et al., 1998). Moreover, some flavonoids such as 
epigal locatechin-3 -gal late (EGCG) (79). diosmin (80) and hesperidin (81) have :n 
demonstrated a chemopreventive effect on nitro samine- induced carcino(-)enesis 
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5.3 Structure-activity relationship of flavonoids 
According to the results obtained in present study, the order of cytotoxiciy of these 
four flavonoids against six cell lines in vitro is luteolin (22) > 7-0-methyl 
aromadendrin (66) > genistein (51) > tectorigenin (24). Typically, genistein (51) and 
tectorigenin (24) are both natural isoflavonoids with low molecular weight (no more 
than 300). They differ from each other by only one methoxyl group in their structures. 
However, the cytotoxicity of genistein (51) is around 200% higher than that of 
tectorigenin (24) against various cancer cell lines in present study. Therefore, the 
methoxyl group at C-6 position on A-ring should be a key function to reduce the 
cytotoxicity of this isoflavone. 
Compared with tectorigenin (24), 7-0-methyl aromadendrin (66) is a flavanone with 
similar molecular weight (MW=302). Nevertheless, it exhibited much higher 
cytotoxicity than genistein (51). The most important difference seems to be the 
hydroxyl function at C-3 position, which is adjacent to the oxo group at C-4. Luteolin 
(22) showed the highest cytotoxicity among those four flavonoids. Comparing with 
other three flavonoids, it has one more hydroxyl function on the B ring, and no 
methoxyl group at C-6 position on the A ring. These characteristics may contribute to 
its high activity. 
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Chapter 5 Discussion 
In order to investigate the potency of flavonoids on antagonist suppression of the 
transformation of cytosolic ary1hydrocarbon receptor (AhR) induced by 2. ). 7.8- 
tetrachlorodibenzo-p-dioxin, 34 flavonoids from natural products have been studied in 
previous work (Ashida, 2000). It was demonstrated that catechins and isoflavones. 
which have the B ring bound to the C-3 position (rather than C-2; see structure 78). 
did not exhibit activity. That means an oxo group at C-4 position and aB ring bound 
at C-2 seems evident for the activity. Furthermore, the flavonoids glycosides showed 
weaker activity than their corresponding aglycones, suggesting that sugar moieties 
could reduce the activity. 
Besides the observation in the present study (luteolin [22] vs luteolin-7-0-glucoside 
[50]), several studies have also reported that sugar moieties quench the bioactivities of 
favonoids when they were tested as glycoside in vitro (Park et al., 2004, Bae et al., 
1999). Practically, those in-vitro bioassays used to evaluate the activites were based 
on cell culture experiments. Therefore the permeability of the cell membrane towards 
the tested compounds should be an essential factor. Obviously, flavonoids are 
hydrophobic compounds and can go though the cell membrane; however, the 
corresponding glycosides are hydrophilic and so usually do not readily enter the cells. 
Thus the flavonoid glycosides can hardly affect the target inside cells, and no activity 
could be observed in vitro. 
5.4 Structure-activity relationship of iridal-type triterpenoids 
Isoiridogermanal (57) isolated from petroleum ether and CHC13 extracts of the root of 
Iris missouriensis (Wong et al., 1986) has been reported to demonstrate strong 
cytotoxicity against P-388 cells (mouse leukaemia) with ED50 of 0.21ýM Another 
study reported that iristectorene B (36), 16-0-acetylisoiridogermanal (82), 3-0- 
tetradecanoyl-16-0-acetylisoiridogermanaI (83), 3-0-decanoyl-16-0-acetylisoirido- 
germanal (84), anhydrobelachinal (85), epianhydrobelachinal (86), belachinal (87) 
and (6R, I OS. IIS, 14S, 26R)-26-hydroxy- I 5-methylidene-spiroirid- I 6-enal (88) were 
isolated from Belamcanda chinensis, and tested for ichthyotoxic activity (Ito et al.. 
1999). Only 16-0-acetyl-isoiridogermanal (82), belachinal (87) and (+)- 
(6R. I OS. IIS, 14S, 26R)-26-hydroxy- I 5-methylidenespiroirid- I 6-enal (88) showed 
potent ichthyotoxic activity against killie fish (Orv.: Ias latipes) with TL. " (median 
tolerance limit after 24h) of 3.5ýtg/ml, -1.8 [ig/ml and 
1.6 ýtg/ml, respectively. All the 
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others showed TL.. higher than 10ýtg/ml (Ito et al., 1999). Distinctively. the 
structures of 36,82,83,84,85,86,87 and 88 are numbered according to the original 
literature, because their names were given based on that system. However. this 
numbering system is not consistent with that of those triterpenes (see Figure 2-19 on 
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By comparing the structures of those tested iridal-type triterpenes. it appears that 
esterification of the 3-OH of the monocyclic triterpenes (using the numbering systeni 
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shown in 79) with a higher fatty acid, markedly lowers toxicity. Ethers such as 
anhydrobelachinal (85) and epianhydro-belachinal (86) were also much less toxic than 
those iridal-type triterpenes having the free 3-OH function. These results indicate that 
the free hydroxyl group at C-3 is important for toxicity. This evaluation is also 
supported by observations in present study, because the four iridal-type triterpenes (57. 
60,61 and 65) with the free hydroxyl group at C-25 (equivalent to C-3 in 82.87 and 
88 ) also exhibited potent cytotoxicity against various cancer cell lines (see Table 3-2 
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5.5 Possible stereostructures of IT4C (61) and IT4D (65) 
The structures of IT4C (61) and IT4D (65) have been elucidated bý' various 
measurements, however, the configuration of some stereo centres in these novel 
compounds are still not certain. Since all isolated monocyclic iridal triterpenoids iii 
the literature have been elucidated to have identical configurations in the six- 
membered ring, it is most likely for the two novel triterpenes isolated in the present 
work to have identical configuration of the six-membered ring. Noticeably, the results 
of 13 C NMR,, 1H NMRý HMQC, HMBC, 1H-1H COSY and NOFSY experiments 
strongly support an identical configuration of the six-membered ring in these novel 
triterpenoids. Where it was possible to determine individual coupling constants, those 
observed (see Table 2-9) were not inconsistent with this proposed structural 
formulation. At the same time, IT4C (61) and IT4D (65) are suspected to be two 
derivatives of isoiridogermanal (57), thus they are likely to be biosynthesized as 
indicated in Figure 2-18 on page 86, and consequentially have identical absolute 
configuration in the six-membered ring and C-14 (R) as in isoiridogermanal (57). 
Therefore, the question left is the configurations of other chiral carbons on their 
structures. 
According to the NOE correlation signals of IT4C (61) (see Figure 2-22 on page 93), 
the correlation signal between H-12 and H-14 clearly indicates that these two 
hydrogen atoms must be on the same side of the plane of the epoxy ring. As a result, 
there are only two possible configurations of the epoxy moiety in IT4C (61), as shown 
in structures 89 and 90 (the key NOESY 'H-1H correlation signal is indicated as blue 
arrow). Therefore, the absolute configuration of the whole molecule is most likely to 
be either of the two stereo structures shown as Figure 5-1 and Figure 5-2. 
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Fillure 5-1: Stereostructure of IT4C (61) with the absolute configuration of epoxv 
ring as 89 
Fiaure 5-2: Stereostructure of IT4C (61) with the absolute confiauration of epoxv 
ring as 90 
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Based on the observed NOE correlation signals (see Figure 2-25 on page 96). it is 
likely that IT4D (65) has a configuration of the six-membered ring identical with 
those of the other three isolated iridal-type triterpenes. The only uncertain absolute 
configuration is that concerning the tetrahydrofuran ring. The stroncy correlation L_ 
signal between H-14 and H-18 suggests that the hydrogen bond of H-14 and the 
carbon bond between C- 17 and C- 18 must be on the same side of the plane in which 
the tetrahydrofuran ring mostly resides. At the same time, the bond of the hydroxyl 
group on C- 16 should be on the opposite side of the plane against the carbon bond of 
17-18, because correlations between H-16 and H-18, and between H-16 and H-19 
were also observed. Thus,, there are two possible absolute configurations of the 
tetrahydrofuran ring (shown as structures 91 and 92). However, if the most likely 
biosynthetic route of IT4D (65) (see Figure 2-18 on page 86) is considered, then the 
configuration of C-14 is most likely to be R, like that of C-14 in isoiridogermanal (57). 
As a result, the stereochernistry of IT4D (65) is most likely to be as in 91, its _31) 
structure shown as Figure 5-3. 
28 
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5.6 Cell cycle speci-fic cytotoxicity in cancer treatment 
It is generally true that anticancer drugs are more effective against proliferating cells 
than against non-proliferating cells (Brown, 1999), because some anticancer drugs are 
most effective against cells in one phase of the cell cycle. Practicallý,, they can be 
classified as S-phase specific (e. g., cytosine arabinoside, hydroxyurea and 
methotrexate), M-phase specific (e. g., vincristine and vinblastine), or cycle phase non- 
specific (e. g., alkylating drugs and antiturnour antibiotics) (Pratt, 1994). 
In the present study, the two isolated flavonoids (tectorigenin [24] and 7-0-methyl 
aromadendrin [66]) showed S and G2/M phases specific cytotoxicity, and 7-0-methyl 
aromadendrin (66) was able to induce apoptosis in the COR-L23 (human non-small 
cell lung cancer) cell line. At the same time, IT41) (65) exhibited cycle phase non- 
specific cytotoxicity and induction of apoptosis in COR-L23. It is therefore cytotoxic 
for cells at any point in the cell cycle (see Table 3-5). 
It is becoming increasingly apparent that apoptosis is a process intimately linked to 
the cell cycle (Meikrantz and Schlegel, 1995). Nevertheless, the cell cycle plays a 
critical role in cherno sensitivity for combination chemotherapy (Mueller et al., 2006). 
This is particularly critical for newly developed chemotherapeutic agents that have 
targeted cell cycle effects. 
However, combination chemotherapy is not be as simple as two or more anticancer 
agents applied at the same time. Because cells undergo growth arrest may be 
protected from apoptosis induced by one agent, they may therefore be ultimately 
resistant to another cytotoxic agent (Shah and Schwartz, 2001). This type of adverse 
antagonistic effect was demonstrated when flavopiridol (93) (a synthetic flavone with 
activity of inhibiting a number of protein kinases) exposure was followed by 
treatment with paclitaxel (94). The multiple cell cycle effects of flavopiridol caused 
cell cycle arrest in G, and Q, phases. This prevented cells from entering M-phase, the 
phase during which paclitaxel is most active; and so led to a significant reduction in 
paclitaxel sensitivity in culture (Motwani et al., 1999). On the other hand. cell cýýcle- 
mediated drug resistance can be overcome by appropriate sequence of the drug 
combination. As a result, the reverse sequence of paclitaxel (94) followed bý- 
flavopiridol (93) is associated with an increased induction of apoptosis (Bible and 
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Kaufmann, 1997). Therefore, the sequence of the multi-drug chemotherapy is critical 
for the exploration of the synergistic effects of cell cycle-specific cytotoxic agents. 
HO 
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5.7 Possible contributions of Iris tectorum in anticancer treatment 
Tectorigenin (24) should contribute to the gross activity of Iris tectorum when it is 
used as Traditional Chinese Medicine, because it is a principal compound in its 
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in an analysis of isoflavone content in rhizornatous medicinal plants belonging to 
Iridaceae. Those plants included Belamcanda chinensis, Iris tectorum, I dichotonw, 1. 
japonica, I germanica, I confusa, I blodow, I lactea var. chinensis, I ensata, I 
sibirica, I sanguinea, I uniflora, I leptophylla, I speculatrix, I versicolor and 1. 
pseudocarus. The proportion of tectorigenin (24) is 1.5% (w/w) in Iris tectorum. but 
no more than 0.22% in the other 15 species of Iridaceae (Qin et al., 1996). 
Beside its antioxidant activity (Jung et al., 2004), tectorigenin (24) in the present 
study showed moderate cytotoxicity with IG50 of 105ýM to 235ýM against various 
cancer cell lines, and arrested cell progress at S and G2/M phases. It has also been 
reported that tectorigenin (24) inhibited angiogenesis in vitro and in vivo. In addition, 
subcutaneously administered tectorigenin (24) at a dose of 30mg/kg for 20 days to 
mice implanted with murine Lewis lung carcinoma, caused a significant reduction by 
30.8% of turnour volume (Jung et al., 2003). At the same time, tectorigenin (24) 
exhibited a much stronger antiproliferative activity than its glycoside (tectoridin [25]). 
As an isoflavone, tectorigenin (24) significantly rectified the aberrant expression of 
several essential gene products involved in prostate cancer (Lee et al., 2001). It was 
reported to down-regulate prostate-derived Ets transcription factor (PDEF), prostate- 
specific antigen (PSA) and insulin-like growth factor-I (IGF-1) receptor mRNA 
expression in vitro (Thelen et al., 2005). It also induced differentiation and apoptosis 
in human promyelocytic leukaemia HL-60 cells in vitro (Lee et al., 200 1). 
7-0-Methyl aromadendrin (66) has been isolated from several plants, including 
Populus alba, Artemisia dracunculus, Eucalyptus maculate and Eupatorium species, 
since 1970 (Stoessl et al., 1971; Herz et al., 1972; Balza and Towers, 1984; Abdel- 
Sattar et al., 2000). However, no bioactivity has been reported. The present work is 
the first report of its isolation from a member of the Iridaceae and its subsequent 
cytotoxicity evaluation. Compared with tectorigenin (24), 7-0-methyl aromadendrin 
(66) showed much higher cytotoxicity with a range of IG50 from 21 ýLM to 40ýIM 
against various cancer cell lines. In addition, it induced apoptosis in COR-1-23 cell 
line and interrupted cell proliferation at S and G2/M phases. 
Those isolated iridal-type triterpenes exhibited high cytotoxicity against cancer cells. 
Since they have been isolated as major components from the cytotoxic fine fraction of 
It-is tectorum, they are supposed to be the principal cYtotoxic compounds in this plant 
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and should contribute significantly to the cytotoxicity of this TCM. However. due to 
the limited amount of pure samples, only IT4D (65) could be tested and show the 
induction of apoptosis in COR-L23 cells. 
In recent years, anticancer research is aimed at the development of new-targeted 
agents, which will likely be used in combination with established cytotoxic drugs 
(Broxterman and Georgopapadakou, 2005). An example of this is the application of 
the humanised anti-VEGF (vascular endothelial growth factor) monoclonal antibody 
Bevacizurnab (Avasting; Genentech, USA) used in combination with cytotoxic 
chemotherapy for colon cancer (Marshall, 2005). 
The rationale for combination chemotherapy has focused on attacking different 
biochemical targets, overcoming drug resistance in heterogeneous tumours, and taking 
advantage of tumour growth kinetics with increasing the dose-density of combination 
chemotherapy. The aim is to improve clinical efficacy at the same time maintaining 
acceptable clinical toxicity (Shah and Schwartz, 2001). 
By combination with standard chemotherapeutic drugs, novel cytotoxic compounds 
with a novel mechanism of action and low toxicity may give some valuable 
synergistic activity (Lenz, 2003). The possible synergistic effects of multi-drug 
chemotherapy in appropriate sequence may result in the improvement of treatment 
against multi-drug resistant cancer and enhancement of cytotoxicity against cancer 
cells with lower toxicity towards the host tissue. For instance, rapamycin (95) 
produced additive cytotoxicity with 5-fluorouracil and cyclophosphamide in a colon 
tumour model,, and the integrated activity was such that it significantly inhibited 
tumour growth at any stage of development (Eng et al., 1984). Further research also 
revealed that rapamycin (95) exhibited additive cytotoxicity against brain cancer cell 
lines when combined with cisplatin (a platinate agent) or camptothecin (96) 
(topoisomerase I inhibitor) (Geoerger et al., 2001). These results indicated that the 
additive cytotoxicity found in combination therapy has great potential in the treatment 
of human cancer. 
There was poor selective cytotoxicity when those isolated compounds (from the active 
fraction of Iris tectorum) were tested against both lung cancer cells (COR-1-2133) and 
lung normal cells (MRC-5). Actually most tested compounds exhibited 
higher 
cN-totoxicit,, - against lung normal cells rather than lung cancer cells (see 
Figure 3)-1 and 
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Figure 3-2 on page 109). However, two most active fractions (IT-3 and 174) showed 
significantly higher cytotoxicity against lung cancer cells than that against normal 
lung cells in the earlier stage of bioassay-guided isolation (see Table 2-5 on page 67). 
The selective cytotoxicity against lung cancer cells is likely based on the preferable 
combination of some active compounds in those fractions. As to TCM used to treat 
cancer, the integrated activity of Iris tectorum ought to be attributed to those isolated 
and still unisolated bloactive compounds. Thus TCM is suggested to be a kind of 
multi-drug treatment with multi-target therapeutic activity. Even those isolated 
compounds in present study could be tested in a combination with standard 
chemotherapeutic agents for investigation of synergistic activity in future work. 
HO/,, 
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